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HORIZON
  
Dichtbij is soms de horizon: 
Mijn blikveld is benauwd en krap 
De wereld is in ballingschap 
Het hier in mij is hoofdstation. 
Ver weg is soms de horizon: 
De ruimte dat ik even snap 
Mijn eigen medezeggenschap 
De verte is mijn peilstation. 
Soms na, soms ver de horizon: 
Bepaal hem zelf bij elke stap, 
Creëer mijn eigen meesterschap, 
De einder is geen eindstation. 
(Ineke Hoonakker)  
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Stroke is the third leading cause of death and the most important cause of long-term 
disability in the adult population in the Western world. In the Netherlands, an esti-
mated 40.000 people suffer a stroke each year and over 200.000 patients have to 
live with its consequences [1]. Stroke incidence is strongly age-dependent, more and 
more patients survive other types of vascular diseases such as coronary heart dis-
ease, and life expectancy is ever increasing. As a result, the number of stroke pa-
tients is expected to increase by 40-50% in the next 20 years. Besides the commonly 
recognized sensorimotor handicaps, stroke has a great impact on cognitive and emo-
tional functioning of patients. 
Vascular cognitive impairment 
Impairment of cognitive function is common after stroke. Studies report the occur-
rence of cognitive impairment in at least one-half of stroke patients, ranging from mild 
cognitive impairment to dementia [2-7]. Physical handicaps rather than cognitive 
deficits generally attract most attention. However, post-stroke cognitive impairment 
has important consequences since it is associated with poorer prognosis and out-
come. Vascular cognitive impairment (VCI) has been proposed as an umbrella term 
to include subjects affected with any degree of cognitive impairment resulting from 
cerebrovascular disease, including vascular dementia (VaD) [8, 9]. There is consid-
erable debate with respect to the specificity of cognitive profiles, anatomical corre-
lates and pathological substrates associated with VCI. 
Neuropsychological profile of vascular cognitive impairment 
The cognitive profile of VCI has been found to be predominantly of the subcortical 
type [10-13]. One of the more robust neuropsychological characteristics of patients 
with subcortical disease is psychomotor slowing and deficits in executive functions 
with relatively preserved language and recognition memory. Executive functions that 
tend to be disproportionately impaired include planning and sequencing, speed of 
mental processing, performance on unstructured tasks and attention. In VCI, speed 
of information processing has consistently been identified as impaired whereas defi-
cits in executive performance and attention are less pronounced [12, 14, 15]. Deficits 
in speed of information processing are found even in patients that do not meet crite-
ria for vascular cognitive impairment [16, 17]. 
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Neuroanatomical correlates of vascular cognitive impairment 
Whereas localized infarction of the cerebral cortex may cause specific disturbances 
of higher cortical functions, ischemic lesions of subcortical grey and white matter 
generally do not result in impairment of a particular cognitive domain. The cognitive 
expression of isolated white matter lesions appears to be limited to mild motor and 
psychomotor slowing rather than a pervasive, severe degree of cognitive impairment 
[18]. Epidemiological studies have established an association of periventricular white 
matter lesions, brain infarction and generalized atrophy with poorer performance in 
certain cognitive domains, particularly information processing speed and executive 
function [19-21]. On the basis of current neuroimaging and post-mortem data, three 
anatomical concepts have been described that may explain VCI [22]: (a) a critical 
volume of accumulated cortical infarcts, (b) strategically localized subcortical infarcts; 
and (c) functional disconnection of neuronal networks. Cortical neuronal loss as well 
as subcortical axonal injury might thus be key elements in the pathogenesis and 
progression of VCI. Moreover, irreversible injury to brain parenchyma causes up-
stream and downstream effects in neuronal networks through mechanisms such as 
anterograde (Wallerian) degeneration, retrograde degeneration and apoptosis. 
Vascular cognitive impairment and cholinergic dysfunction 
There is abundant evidence that the basal forebrain cholinergic system plays a major 
role in cognitive performance. The central cholinergic system consists of a diffuse 
neuronal network of projections from several basal forebrain nuclei towards the cere-
bral cortex and hippocampus which exerts its function at synapses through the en-
dogenous neurotransmitter acetylcholine. The knowledge on cholinergic function in 
cognition stems from psychopharmacological studies on the effects of cholinergic 
drugs in humans [23-25], as well as studies using pharmacological manipulations and 
selective lesioning of basal forebrain cholinergic neurons in animals [26-31]. Recent 
experiments suggest that cholinergic neurons serve a modulatory function by optimiz-
ing cortical information processing and influencing attention [32]. Based on these 
studies, a strong correlation between cognitive performance and cholinergic function 
has been established. 
 Vascular cognitive impairment associated with cholinergic dysfunction has mainly 
been investigated in vascular dementia (VaD) and Alzheimer’s disease (AD) [33]. 
Recent evidence shows that deficits in cholinergic neuronal markers and degenera-
tion of neuronal circuits contribute to cognitive decline in both AD and VaD. This 
suggests that central cholinergic function is impaired in VaD, which may underlie the 
General introduction  
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cognitive and functional deficits characteristic of VCI. Vascular cognitive impairment 
in VaD may arise directly from ischemic loss of cholinergic neurons in basal forebrain 
nuclei. Alternatively, loss of cognitive function may arise indirectly, following ischemic 
damage to cortical and subcortical cholinergic pathways. 
Experimental stroke research and cognitive impairment 
Ischemic stroke is a disease with a complex multifactorial pathophysiology. Animals 
models of focal cerebral ischemia are valuable tools to study the underlying mecha-
nisms, and by that are widely used in the development of novel treatment regimens 
for ischemic cerebral injury [34-37]. Most of the experimental stroke models are car-
ried out on rodents, and each model has its particular strengths and weaknesses. 
Focal cerebral ischemia can be induced by common carotid artery occlusion, middle 
cerebral artery occlusion, and microcirculatory occlusion [38]. Mimicking all aspects 
of human ischemic stroke in a single animal model is not possible, since ischemic 
stroke itself is a very heterogeneous disorder. The photothrombotic model described 
in this thesis produces coagulation of the cortical microcirculation. The permanent 
vascular occlusion resulting from endothelial damage and platelet aggregation re-
sembles the pathophysiology of cerebral ischemia due to injury of a small vessel in 
humans [39]. The advantages of the model include its non-invasiveness (no craniec-
tomy is required, merely retraction of the skin over the skull), high reproducibility (of 
lesion size and location), and short procedure duration (such that subsequent behav-
ioural studies can be undertaken within hours). The development of tissue damage is 
very rapid and without reperfusion or collateral blood flow. In this respect, however, 
the model has relatively limited clinical relevance and has shown little positive results 
in studies testing possible neuroprotective agents [40]. 
 In search of neuroprotective drugs in acute stroke, a vast amount of experimental 
stroke research has been aimed at preventing or ameliorating structural damage after 
an ischemic insult. This approach has thus far not yielded a standard pharmacologi-
cal therapy of use in clinical neurological practice [38, 41, 42]. Traditionally, post-
stroke damage has been assessed structurally by comparing histological examination 
in animal models that did or did not receive a pharmacological treatment. Many 
stroke researchers have nowadays expanded their techniques to assess the effects 
of stroke functionally by using long-term behavioural correlates of histologically-
determined brain infarction in animal models [43]. As compared to motor perform-
ance, however, cognitive performance is seldomly used as a functional behavioural 
endpoint in experimental stroke research. 
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The vast majority of studies on behavioural outcomes of experimental stroke has 
been conducted in rodents. Various studies have shown impaired performance in 
behavioural tasks measuring cognitive processes such as attention, learning and 
memory [44-49]. However, most experimental stroke models typically produce exten-
sive damage in both cortex and subcortex resulting in disturbances of sensorimotor 
abilities [50]. Alterations in motor function, sensory capabilities, or motivation can 
become confounding factors when measuring cognitive performance. Moreover, 
mnemonic functions are relatively preserved in VCI. Studying vascular cognitive 
impairment in an experimental setting may therefore require the use of a relatively 
restricted lesion model and behavioural tasks measuring cognitive functions other 
than learning and memory. 
Aim of the thesis 
The present thesis explores the putative relationship between the development of 
vascular cognitive impairment and damage to the central cholinergic system in an 
animal model of cerebral infarction. It is assumed that disruption of cholinergic path-
ways secondary to focal infarction of the cerebral cortex in the rat results in impaired 
cognitive performance. 
 
(a) The first objective was to establish an equivalent of human vascular cognitive 
impairment in an animal model of focal cerebral infarction. 
(b) The second objective was to characterize structural and functional changes to 
the central cholinergic system after focal cerebral cortical infarction. 
Outline of the thesis 
Vascular cognitive impairment in humans is thought to result from a combination of 
localized damage to both grey and white matter, as well as functional disconnection 
of neuronal networks by cerebral ischemia. There are numerous animal models to 
study experimental brain ischemia. The photothrombotic model is able to produce a 
relatively small focal infarction of the cerebral cortex, which allows for the investiga-
tion of (1) cognitive effects without confounding by gross sensorimotor deficits and (2) 
local as well as remote changes to cholinergic neurotransmission. We first performed 
an in vivo study to further clarify the pathophysiological processes that lead to brain 
infarction in this photothrombotic model. As such, chapter 2 describes the contribu-
tion of vascular leakage in the development of photothrombotic infarction. 
General introduction  
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The first objective of this thesis was to establish an equivalent of human vascular 
cognitive impairment in an animal model of focal cerebral infarction. The neuropsy-
chological profile of VCI is typically characterized by deficits in psychomotor process-
ing speed and attention performance. Both types of deficits were studied separately. 
First, in chapter 3, a reaction time task is used to detect whether information proc-
essing speed is slowed following unilateral photothrombotic infarction of the frontal 
cortices in rats. Second, chapter 4 studies whether performance is impaired in a 
behavioural paradigm measuring sustained attention performance after photothrom-
botic infarction of either the frontal or parietal cortex in rats. Also in this chapter, the 
involvement of the cholinergic system in cognitive performance is described by meas-
uring whether sustained attention is reduced after pharmacological cholinergic mus-
carinic receptor blockade. 
 The second objective of this thesis was to characterize functional and structural 
changes to the central cholinergic system after focal cerebral cortical infarction. To 
this end, a method was sought that would enable whole-brain assessment of the 
cholinergic system in a living animal. Chapter 5 describes the feasibility of pharma-
cological functional magnetic resonance imaging (phMRI) as a means to detect cho-
linergic muscarinic receptor activation in rat brain. Subsequently, we tested the appli-
cability of this neuroimaging method to measure cholinergic muscarinic receptor 
activation after subcortical brain infarction (appendix). This was done in order to 
investigate cholinergic function after direct ischemic damage of basal forebrain cho-
linergic neurons projecting toward the cerebral cortex. The reverse is described in 
chapter 6, where remote cholinergic muscarinic receptor activation as well as cho-
linergic cell number in the basal forebrain were studied after photothrombotic infarc-
tion to the frontal cortex. Finally, a general discussion is presented in chapter 7. 
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ABSTRACT 
The photothrombotic model for stroke was originally described as a focal cortical 
infarction resulting from occlusive thrombosis. However, subsequent studies have 
shown evidence for extravasation of water and proteins using ex vivo techniques. 
The aim of the present study was to determine the role of vascular leakage in the 
pathophysiology of photochemically induced infarction in vivo. At several time points 
after infarct induction, analysis of blood flow and vascular leakage was performed 
using intravital microscopy and fluorescent labelling of blood plasma. In the first hour 
following infarct induction, massive vascular leakage of the plasma label occurred 
inside the lesion core that was destined to become infarcted. Flow had stopped com-
pletely in this area at 4 hours after illumination. On the day following infarct induction 
substantial leakage was still present in the penumbral area, defined as the area im-
mediately surrounding the lesion core where reduced flow velocities were observed. 
Thus, together with the formation of occlusive thrombi, vascular leakage is an impor-
tant factor in the pathophysiology of photothrombotic stroke. 
The photothrombotic model for cortical infarction  
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INTRODUCTION 
The use of a photochemical reaction to produce focal cortical infarction in the rat 
brain was first described in 1985 [1]. Although the use of light-dye reactions to initiate 
platelet aggregation in the cerebral microcirculation had been described earlier [2], 
Watson et al. [1] were the first to advocate this photochemical reaction as a means of 
mimicking cerebrovascular occlusive disease i.e. ischemic stroke. By using transcra-
nial illumination with a filtered light source in combination with intravenous injection of 
a photosensitive dye, they were able to produce vascular thrombosis. Light micros-
copy and scanning electron microscopy showed intravascular thrombotic material, 
red blood cell stasis, and platelet aggregates adhering to luminal surfaces inside pial 
and parenchymal vessels within superficial layers of the irradiated cortex. Based on 
these findings, intravascular thrombosis was deemed responsible for the occurrence 
of ischemia leading to infarction. Subsequent studies, however, investigated the 
integrity of the blood-brain barrier [3-8], since the aggregation of platelets was found 
to be caused by endothelial damage [9]. Histological methods were applied to show 
that protein extravasation was widely distributed within the illuminated zone whereas 
extravascular increases in water content were restricted to the irreversibly damaged 
site, suggesting increased permeability through disruption of the blood-brain barrier 
by the photochemical reaction. 
 The aim of the present study was to determine the temporospatial distribution of 
blood-barrier disruption i.e. vascular leakage in the pathophysiology of photochemical 
cortical infarction in vivo. This was done with the use of intravital microscopy to visu-
alize microcirculatory cortical blood flow and extravasation of a fluorescent blood 
plasma label. 
MATERIALS AND METHODS 
Animals 
All experimental procedures were approved by the local ethical committee for animal 
experiments of University Maastricht and met government guidelines. Fifteen young 
adult Lewis rats (LEW/M, Maastricht, the Netherlands) were obtained from the local 
animal breeding facilities. The animals were housed in standard type III Makrolon 
cages, 3 rats per cage, on sawdust bedding in an air-conditioned room at approxi-
mately 21°C with 45-55% humidity under a 12/12-h light/dark cycle (lights on from 
7.00 to 19.00 h). They had ad-libitum access to food and water. At the time of ex-
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perimental procedures the rats were 12 weeks of age and weighed between 300-340 
grams (male) or 170-200 grams (female). 
Photochemical infarction 
Animals were sedated with halothane, weighed and subsequently intubated for me-
chanical ventilation using a UNO Micro Ventilator (UNO Roestvaststaal BV, Zeve-
naar, The Netherlands). Anaesthesia was maintained with 2% halothane in a mixture 
of 70% nitrous oxide and 30% oxygen (frequency 90 times/min, volume setting 12). 
Body temperature was monitored and regulated using a rectal probe and water-
heated pad. A tail vein cannula was inserted for intravenous injection of the photo-
sensitive agent. The scalp was incised and periosteum removed to expose the skull. 
A perforated piece of filtration paper was placed over the right parietal bone, centred 
at 2.7 mm posterior and 2.7 mm lateral to Bregma’s point, to absorb possible leakage 
of blood. The light source (diameter 2.4 mm) was positioned at right angles to the 
skull surface in the centre of the perforated filtration paper (Figure 1). 
 
Figure 1. Illustration depicting the right parietal bone of the rat skull. Beam diameter of the light source 
(2.4 mm) and position of illumination (centred at 2.7mm posterior and 2.7 mm lateral to Bregma) are 
shown as a white circle; the cranial window is shown in shaded grey. Bregma lies at the intersection of 
the coronal and sagittal sutures; Lambda lies at the intersection of the occipital and sagittal sutures. 
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The irradiating apparatus was custom-made by Instrument Development Engineering 
& Evaluation (IDEE, University Maastricht) from a diode-pumped solid-state laser 
(beam diameter: 0.6mm; wavelength: 532 nm; JDS Uniphase, Germany) with a 4x 
optical laser lens beam expander, mounted on an adjustable hydraulic arm. Power 
output was measured at 12.3 mW, averaging a calculated beam intensity of 300 
mW/cm2. Each animal was intravenously injected with 20 mg/kg bodyweight Erythro-
sin B (Sigma-Aldrich) dissolved in a sterile solution of 0.9% sodium chloride and 
subjected to 0.2 μm filtration, followed by flushing with 0.9% sodium chloride to a 
total volume of 1500 μl over a 2-minute period. Then the cover of the light source 
was removed and the skull was illuminated for 2.5 minutes. Additional cooling of the 
skull surface to prevent heat-induced cortical damage was deemed unnecessary, 
given the beam intensity to be below 600 mW/cm2 [1, 10]. 
Intravital microscopy 
Intravital microscopy was performed within the first hour after induction of photo-
chemical infarction, 4 hours after induction, or the following day (n=5 for each time 
point). Animals were sedated through an intraperitoneal injection of xylazin (12 
mg/kg, CEVA Santé Animale), and anesthetized with an intraperitoneal bolus injec-
tion of ketamin (60 mg/kg, Eurovet Animal Health). Anaesthesia was maintained with 
ketamin (20 mg/kg), administered subcutaneously every 30 minutes. Animals spon-
taneously breathed normal air. Throughout these experiments, rectal temperature 
was monitored and maintained at 36.5–37.5° Celsius by a feedback regulated heat-
ing lamp. A cannula was placed in the right femoral vein for the administration of a 
fluorescent blood plasma label. The animals that were imaged within 1 hour after 
infarct induction, received Erythrosin B via the femoral vein cannula instead of a 
lateral tail vein cannula. The head of each rat was fixed in a stereotaxic frame (David 
Kopf Instruments). Using a dentist drill (EM 2900 A; Berger Technik), craniotomy of 
the right parietal bone was performed 1-2 mm inside coronal, sagittal, and lambdoid 
sutures and attachment of temporal muscle, leaving the dura mater intact (Figure 1). 
Additionally, in several animals the left parietal bone was also removed for control 
measurements in normal vasculature. 
 Microscopic observations of the brain microvessels were performed with an 
intravital microscope (all components: Leitz, Wetzlar, Germany). A Ploemopak 2.2 
incident illuminator (tube factor 1.25x), a mercury arc (100 W), and either a 6.5 objec-
tive (numeric aperture (n.a.) 0.18) or an LL25 objective (n.a. 0.35) were used for 
bright-field microscopy. Application of a POL cube (polarizer, 50% mirror, and 
crossed analyzer) minimized direct light reflections from the brain surface. Fluores-
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cence microscopy was performed using a SW 25 objective (n.a. 0.6). Images were 
projected onto a CCD camera, or in case of fluorescence microscopy onto an intensi-
fied CCD camera (C2400-8; Hamamatsu Photonics, Hamamatsu City, Japan), and 
recorded on videotape or DVD. While keeping the dura mater moist with a sterile 
saline solution, the cranial window was first scanned back-and-forth from anterior to 
posterior using the 6.3x objective to obtain a general overview and, subsequently, at 
25x magnification for a more detailed visualization. In areas where blood flow was 
present, arterioles or venules were identified according to the direction of flow. That 
is, convergence of flow is only seen in venules, whereas divergence of flow indicates 
arterioles. Subsequently, blood vessels were selected for fluorescent imaging of 
blood plasma. To this purpose, FITC-labelled dextrans (10-70 kDa) were adminis-
tered (0.5 ml of 5 mg/ml saline, i.v.) that were visualized using filter set I2 (excitation 
BP 450-490 nm; dichroic mirror RKP 510; barrier LP515). After injection of the fluo-
rescent plasma label, video or DVD images of one or two vessels per animal were 
recorded per time point; total recording time was 20 minutes. 
Image analysis 
Off-line, flow patterns in arterioles and venules in the cranial window were assessed 
at 25x magnification. Per optical field (310 by 230 μm) the flow pattern of all vessels 
was scored semi-quantitatively as either “fast flow” (+) if no individual red blood cells 
could be discriminated in the blood stream, “slow flow” (=) when individual, moving 
red blood cells were observed, or “no flow” (-). If different flow patterns occurred in 
the same optical field, flow in small vessels (< 30 μm) was noted first and separated 
from flow in larger vessels by a forward slash. At each border of the cranial window at 
least two optical fields were discarded from analysis, because of artefacts caused by 
the experimental procedure (e.g. drilling). Exemplary results are shown in Figure 2. 
Because of inter-individual differences in size of the cranial window, no group averag-
ing was performed on the flow pattern data. However, based on these flow patterns, 
data on vascular leakage could afterwards be interpreted for every single animal as 
being recorded in normal areas (fast flow areas), peri-infarct or penumbral areas 
(slow flow), or infarcted areas (no flow). 
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Digitized video images or DVD images were imported in Adobe Photoshop to enable 
quantification of fluorescent plasma label leakage from brain microvessels. The use 
of Adobe Photoshop for quantitative image analysis of cerebral microcirculation was 
adapted from [11]. Three identical circular areas were drawn that covered the com-
plete intravascular space (one circle) and its immediate surroundings (two circles on 
opposite sides of vessel). The diameter of each circle equalled vessel diameter. 
Special care was taken with the placement of the circles in order to minimize possible 
interference from neighbouring vessels. The average of mean grey values in the 
extravascular circles was divided by the mean of the grey values inside the intravas-
cular circle, resulting in ratios of fluorescence levels outside and inside the blood 
vessel. Such ratios were determined in every animal over the 20-minute time frame 
after FITC-dextran administration, and thus, represent the level of plasma label leak-
age from the vessels. As mentioned before, one or two vessels (generally one arteri-
ole and a venule) were recorded per animal per time point, and twice as much when 
control measurements were performed on normal vasculature. 
Figure 2. Quantification of flow patterns inside the cranial window. Per optical field, the flow pattern of 
the vessels was scored semi-quantitatively as either “fast flow” (+), “slow flow” (=) or “no flow” (-). The 
optical fields showing a stripe pattern indicate the areas in which quantification of vascular leakage was 
performed. For every time point observed, one exemplary result is given: within 1 hour after infarct 
induction (A), after 4 hours (B), and the next day (C). At earlier time points penumbral areas were 
usually larger in size, and frequently, various flow patterns per optical field were observed, especially 
after 4 hours. On the day following illumination, a clear distinction was visible between infarcted and 
non-infarcted areas. Abbreviations: ANT = anterior, POS = posterior, MED = medial, LAT = lateral. 
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Data analysis 
For every post-lesion time point, the fluorescence ratios were averaged per vessel 
type. Parts of the analyses were performed independently by two authors (EH and 
MOE). The inter-rater variability of these data was good (kappa 0.8). All data were 
compared in a repeated measures analysis (SPSS, version 11). Within-subject factor 
was the time after FITC-dextran injection (Time - 5 levels) and between-subjects 
factor was vessel type per time point. In order to specify the time point at which arte-
rioles and venules were leaky, pair wise comparisons were made with the estimated 
marginal means of the corresponding control vessel type using a Sidak adjustment 
for multiple comparisons (p=0.05). 
Histology 
With intravital microscopy through a cranial window, one can only observe the micro-
circulation at the cortical surface. In addition, pial microvessels are observed that 
may have different properties in terms of permeability compared to cerebral mi-
crovessels [12]. To be able to extend our findings to deeper cortical vessels and 
blood-brain barrier integrity, we intravenously injected a 2% Evans Blue dye solution 
(Sigma-Aldrich) at the end of intravital microscopy [13]. The animal was sacrificed 30 
minutes later. For macroscopic analysis of vascular leakage, brains were snap-
frozen, cryostated and contingent presence of the blue dye verified. 
RESULTS 
Flow pattern 
In the animals where craniotomy was performed on the side contralateral to illumina-
tion, normal vascular architecture with fast flow patterns was observed. The posterior 
part of the cranial window that had not been illuminated also showed normal vascular 
architecture with fast flow patterns, independently of the time period following induc-
tion of photochemical infarction. Figure 2 illustrates that within the first hour after 
infarct induction, slow flow as well as no flow was observed in vessels inside the 
illuminated zone, together with the occasional passage of thrombotic-like material. 
After 4 hours, vessels with slow flow or no flow were observed as well, but the area 
with no flow-vessels increased. Strikingly, disturbances in flow were observed more 
often in smaller vessels (diameter < 30 μm) than in larger ones (diameter > 30 μm). 
On the day following illumination, flow had stopped in all vessels within the illumi-
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nated zone. Therefore, this zone is referred to as the lesion core. In the immediate 
surroundings of this lesion core, slow flow was observed after 4 hours. On the follow-
ing day this area had reduced to only a few optical fields. We refer to this slow flow 
area, between lesion core and normal flow area, as the penumbra. Within the first 
hour after induction, we were not yet able to identify this region. 
Vascular leakage 
Initial intravital microscopy experiments were aimed at defining the optimal size of 
FITC-labeled dextrans to be used for quantitative analysis of vascular leakage. With 
injection of 10 kDa dextrans an almost immediate and massive increase in perivascu-
lar fluorescence was seen inside the irradiated zone. After injection of 70 kDa dex-
trans, fluorescence in this area barely increased. For this reason, all further experi-
ments were conducted using 40 kDa FITC-labeled dextrans. 
 Analysis of images obtained from venules and arterioles of the hemisphere con-
tralateral to the illumination site showed no increase in fluorescence ratio (Figure 3A), 
which means that normal non-infarcted cerebral microvessels are impermeable to 40 
kDa dextrans. During the 20-minute imaging sessions, even a slight decrease was 
found, indicating natural clearance of the plasma label from the blood circulation. 
Data obtained from arterioles and venules inside the illuminated area are presented 
for every post-lesion time point (Figures 3B-C). Since blood flow inside the lesion 
core was only detectable immediately after infarct induction, no data could be ob-
tained from this area at later time points. Within the first hour of illumination, the ratio 
of extravascular over intravascular fluorescence of both arterioles and venules inside 
the lesion core increased from control values to 0.8 -1.0 over the 20-minute recording 
period. These data indicate that inside the lesion core both arterioles and venules 
become leaky within the first hour after photochemical induction of cortical infarction. 
As stated before, fluorescent imaging of vessels inside the lesion core was not possi-
ble after 4 hours and on the day following induction of infarction, because of a lack of 
blood flow. At these time points a normal and regular distribution of the plasma label 
was seen both in arterioles and venules of the penumbra. At 4 hours a relative in-
crease in extravascular fluorescence was observed in arterioles as well as venules. 
At the end of the 20-minute recording time, the ratios were found to be similar to 
those found in the lesion core within the first hour (0.75-1.0). On the day following 
infarct induction, arterioles and venules again showed a similar increase in fluores-
cence ratios after administration of the plasma label (to 0.90 and 0.68, respectively). 
These data suggest that vessels are leaky in the penumbra as well. On the other 
hand, no signs of thrombosis were observed. 
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Figure 3. Ratios of extravascular over endovascular fluorescence in time after injection of FITC-labeled 
dextran (40 kDa). Based on flow pattern and location of the optical field inside the cranial window, fluores-
cence ratios in every single rat could retrospectively be assigned to either lesion core or penumbral areas. 
Individual measurements were averaged per vessel type for every time point after infarct induction. Measure-
ments from control vessels were obtained from a cranial window on the contralateral side of illumination (A) 
and show a slight decrease in fluorescence ratio, suggestive of natural clearance from the blood stream. By 
contrast, an increase in this ratio is seen in arterioles and venules at every post-lesion time point (B and C). 
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Statistical analysis confirmed the observation of vascular leakage. Repeated-
measures analysis showed a significant effect of time after FITC-injection 
(F(4)=133.24, p<0.001). Pairwise comparison between arterioles demonstrated that 
leakage was still present after one day of infarct induction (p<0.05), whereas the 
same comparison for venules revealed significance at 4 hours (p<0.02) and a trend 
at 1 hour (p=0.10). No differences were found between leakage ratios at baseline. 
Vascular leakage was also confirmed macroscopically after intravenous injection of 
the dye Evans Blue. In undamaged brain areas like cerebellum and contralesional 
hemisphere no dye leakage was found. At all time points after infarct induction, how-
ever, Evans Blue was observed to have extravasated at the lesion site on the cortical 
surface, and was often found to be dispersed a few millimetres over the ipsilesional 
hemisphere. This is in accordance with the intravitally obtained data. In deeper corti-
cal layers, Evans Blue was present throughout the extension of the lesion within 1 
hour of infarct induction, and in its immediate surroundings (the penumbra) up until 
one day after infarct induction. The lesion core did not show leakage of Evans Blue 
from 4 hours onwards, which is in accordance with the absence of flow in vessels 
within this area. 
DISCUSSION 
The present study investigated vascular permeability of the cortical microcirculation 
after photochemically induced cortical infarction in vivo. This was done using intravital 
microscopy and fluorescent labelling of blood plasma, which enables real-time visu-
alization and quantification of changes in flow and permeability in different vessel 
types. As a result, the temporospatial distribution of blood-barrier disruption could be 
determined. We have found extensive vascular leakage of the 40 kDa plasma label 
from superficial, cortical arterioles and venules within the illuminated area and its 
penumbra up to one day following induction of infarction. In agreement with findings 
by Belayev et al. [13], the extravasation of Evans Blue within the entire ischemic area 
shows that these results are applicable to deeper cortical microcirculation as well and 
reflect disruption of the blood-brain barrier. 
 In previous studies using histological methods, it has been evidently shown that 
blood-brain barrier disruption is a fundamental mechanism in the development of 
photochemically induced cortical infarction. Dietrich et al [3] demonstrated that a 
complete cortical lesion could be obtained in the absence of thrombosis by cooling 
the brain by 3 ºC. Furthermore, Haseldonckx et al. [7] described that minimizing the 
photochemical challenge to endothelial membranes modifies the photothrombotic 
stroke model into one that models the ischemic penumbra. Using a lower concentra-
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tion of the photosensitizer and a shorter duration of illumination at lower output, they 
showed limited congestion of microvessels by erythrocytes and extensive blood-brain 
barrier leakage of ultrasmall gold particles within minutes to 1 hour after illumination. 
Thereafter, progressive intravascular congestion occurred, which was attributed to 
extravasation and consequent formation of perivascular oedema. These findings 
were compared to those seen when photochemical induction of infarction was per-
formed at higher concentration of photosensitizer with longer illumination at higher 
output. Almost immediate congestion of cortical microvessels was found, whereas 
leakage of gold particles was mainly situated at the margins of the thrombotic core. 
 Although it seems that these findings contradict to the role of vascular occlusion 
by platelets in the original description of the model, we recognize both ‘thrombosis’ 
and ‘leakage’ as well-accepted events in the pathophysiology of the photochemical 
model. These events largely depend on the concentration of the photosensitive 
agent, irradiation parameters and physiological circumstances at the time of the pho-
tochemical procedure. Thus, it might well be that the sequence of events at higher 
photochemical challenge takes place in a shorter time frame. An alternative explana-
tion, as derived from our findings, is that aggregation of platelets may largely account 
for vascular occlusion in small vessels (<30 μm) whereas vascular leakage mainly 
contributes to the stasis of blood flow in larger ones. In accordance, we have found 
that flow decreased or stopped first in small vessels 4 hours after infarct induction. 
And although we did observe the occasional passage of thrombotic-like material in 
larger vessels, especially inside the lesion core, flow in these vessels was still pre-
served for at least 4 hours after infarct induction. However, since we were unable to 
monitor brain temperature, cooling of the brain surface may have occurred. This 
could have resulted in a decreased aggregation of platelets [3], which in turn, may 
have led to a relative overemphasis of the vascular leakage component in this study. 
It has been stated that, in this animal model, the formation of occlusive thrombi oc-
curs before disruption of the blood-brain barrier [14], suggesting that these thrombi 
are the cause of ischemia ultimately leading to infarction. Whereas we did observe 
vascular irregularities and possible thrombus formation on the endothelial wall in the 
illuminated area within the first hour after infarct induction, microcirculatory blood flow 
was still present together with a massive leakage of the 40 kDa plasma label, indica-
tive of early damage of the blood-brain barrier. Therefore, the lack of blood flow in the 
illuminated zone after 4 hours may not be caused by the formation of occlusive 
thrombi alone, but also by massive leakage of proteins and fluids across a damaged 
blood-brain barrier. Together, this will lead to a reduction in blood flow and eventually 
to stasis of red blood cells in pial and parenchymal cortical vessels, as was originally 
described by Watson et al. [1]. 
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Secondary ischemia due to compression of microvessels by cerebral oedema is used 
as an explanation of gradually expanding infarction outside the original area of illumi-
nation [7, 10]. The relationship between cerebrovascular permeability and cerebral 
oedema was described by Laursen et al. [5], who showed increased permeability of 
the blood-brain barrier to serum proteins from two hours onwards after photochemical 
induction of cortical infarction. Although our results demonstrated that blood vessels 
in the immediate surroundings of the lesion core are still leaky one day after photo-
chemical challenge, we could not confirm a substantial expansion of infarction. Based 
on our findings, this is due to (a) the preservation of blood flow outside the illuminated 
area, and (b) the extravasation of Evans Blue, which appeared to be more wide-
spread at 4 hours than one day after infarct induction. After photochemical challenge, 
however, blood-borne factors are known to be released and are proposed to increase 
vascular permeability [15]. This might explain why higher concentrations of photo-
sensitive dye and longer illumination duration produce larger infarction, and con-
versely, the lack of expansion found in our application of the model. 
 In conclusion, we have found extensive leakage of a large protein from arterioles 
and venules in the superficial cortical microcirculation after photochemically induced 
infarction. In addition, we have shown that these results are applicable to deeper 
cortical microcirculation. Thus, apart from occlusive thrombi, the pathophysiology of 
photothrombotic stroke also includes substantial disruption of the blood-brain barrier. 
Moreover, differential effects may exist with respect to vessel diameter. Small vessels 
may be more prone to early intravascular occlusion through thrombi formation, 
whereas in larger vessels vascular leakage continues for longer periods of time. 
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ABSTRACT 
Reaction time performance reflects the speed of information processing, both in 
humans and lower vertebrates like the rat. The present study compared reaction time 
performance in rats following unilateral infarction to the frontal cortex. The objective 
was to model cognitive impairment as it is seen in humans after stroke. Rats were 
trained in a reaction time paradigm, after which unilateral cortical infarction was in-
duced photochemically. Reaction time performance was differentially affected after 
unilateral infarction to either the left or right frontal cortex, whereas sham-operation 
did not result in a significant alteration in reactivity. An overall increase in reaction 
time of about 10% was present at four weeks after frontal infarction. In addition, a 
lateralized reaction time deficit occurred very early after right frontal infarction as an 
increase of 10-15% in trials directed towards the contralesional side. Additional 
analyses showed that these reaction time deficits can be explained differently: the 
former as a gradual and general decrease in the speed of information processing, 
whereas the latter shows specific impairment to initiate a contralateral motor re-
sponse. The former matches well with the mental slowing observed in stroke pa-
tients, whereas the latter resembles a neglect phenomenon. We conclude that meas-
uring reaction time performance after frontal cortical infarction in rats could offer a 
useful tool to model particular human cognitive impairments following cerebral infarc-
tion. 
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INTRODUCTION 
Cerebrovascular disease is the second most common cause of acquired cognitive 
impairment and dementia [3]. A general slowing in the speed of information process-
ing is frequently encountered, which is most prominent when time pressure is part of 
a task performance [4-8]. Both in humans and in lower vertebrates like the rat, the 
latency to respond (reaction time) is a direct measure of information processing 
speed [9]. In clinical and experimental neuropsychology, therefore, reaction time is an 
accepted measure in the assessment of cognitive function. The use of reaction time-
based parameters has contributed greatly to the present knowledge of information 
processing in humans. In animal research, reaction time testing has mostly been 
limited to studies on mental slowing in aging and to the role of the striatum in the 
facilitation of movements (Parkinson’s disease). However, it could offer the possibility 
to study basic mechanisms behind disturbances of higher cortical functioning after 
cerebral infarction. Thus far, reaction time experiments into information processing 
after cortical damage have mostly studied bilateral cortical lesioning [10-18] or unilat-
eral cortical lesioning of a single hemisphere [19-22]. To our knowledge, no studies 
have been published in which a direct comparison is made between reaction time 
performance after unilateral lesions to the left or the right frontal cortex. 
 The objective of the present study was to investigate whether the general slow-
ing of cortical information processing speed in stroke patients can be modelled. To 
this end, we investigated the effects of unilateral cortical infarction on reaction time 
performance in rats. We focussed on the frontal cortex, as it is both frequently in-
volved in cerebrovascular disease and in the temporal organization of behaviour [23, 
24]. Since lateralization of brain functions is known to occur within the rodent brain 
[25-30], a direct comparison was made between reaction time performance after 
unilateral lesions to the left versus the right frontal cortex. 
MATERIALS AND METHODS 
Animals 
All animal surgical and maintenance procedures were approved of by the local ethical 
committee of Maastricht University and are in agreement with governmental guide-
lines. A total of thirty-two male Lewis rats were used, which at the time of the surgical 
procedure were 12 weeks of age and weighed 250-300 g. The rats were housed 
individually in standard type III Makrolon cages, on sawdust bedding in an air-
conditioned room of about 21°C with 45-55% humidity under a reversed light/dark 
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cycle (lights on from 19.00 to 07.00 h) and had ad libitum access to water. To prevent 
a motivational bias during behavioural testing, the rats were food-restricted and given 
12-14 g laboratory chow per day. In the weekends, the rats had ad libitum access to 
food up until 12 hours prior to testing. In doing so, the weight of the animals was kept 
at 90% of a freely-fed reference group. We compared unilateral infarction to the left 
frontal cortex and the right frontal cortex (n=10 in each group). A group of sham-
operated animals served as controls (n=12). 
 
Figure 1. Schematic representation of the behavioural paradigm, showing the operating wall of the Skin-
ner box (top) and the series of stages in the reaction time task. Abbreviations: RT (reaction time) = the 
difference in time elapsed between auditory stimulus and panel release. MT (motor time) = the difference 
in time elapsed between panel release and level press. PR (premature responses) = panel release before 
the end of the hold duration. 
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Behavioural training 
The rats were trained to perform a reaction time task [31], of which Figure 1 shows a 
schematic representation. First, the rats learned to push back a hinged panel to re-
trieve a food reward (45 mg food pellets, Bioserve Inc.). The next stage of training 
consisted of continuous reinforcement training, in which either the left or the right 
lever was inserted into the conditioning chamber after the rat had pressed the hinged 
panel of the food tray. Then, the rats had to push the hinged panel for a longer dura-
tion until one of the levers was inserted into the chamber. 
 A randomly chosen time period termed ‘hold duration’ was used (600 – 1500 ms, 
increment 100 ms). When the hold duration had elapsed an auditory stimulus was 
presented. A high tone (10 kHz, 80 dB) required pressing the left lever whereas a low 
tone (2.5 kHz, 80 dB) required pressing the right lever. At the final stage of training, a 
50% partial reinforcement schedule was applied. A single session lasted until 60 
trials had been performed within a maximum of 30 minutes. Baseline measurements 
were calculated after the rats showed stable performance, that is, no change in reac-
tion time performance on five successive training days. This was done by averaging 
the last six sessions of the alternate three weekdays prior to surgery to average out a 
possible bias in testing (time of the week). 
 The main behavioural outcome parameters used for the statistical analyses 
were: (1) Reaction Time (RT), the latency between tone onset and panel release, is 
determined by a simple movement (retraction of the head) and dependent on atten-
tional function, sensory processing, response selection and motor initiation; (2) Motor 
Time (MT), being the latency between panel release and lever press, involves a 
skilled bodily movement reflecting motor execution; and (3) Premature Responses 
(PR) is a measure of response inhibition. PR were scored when the rat released the 
panel before the end of the hold duration. A ratio was calculated by dividing the num-
ber of premature responses by the total number of trials. 
Surgery 
Within each experiment, body weight and reaction time were matched in both lesion 
groups prior to surgery. Cortical infarction was induced by photochemically initiated 
thrombosis [32, 33]. This method was chosen because it produces highly reproduci-
ble, circumscript damage of cortical structures. Animals were anaesthetized with 2% 
halothane in a mixture of 70% nitrous oxide and 30% oxygen, and allowed to breathe 
spontaneously. Body temperature was feedback-controlled between 36.5 – 37.5 ºC 
by a rectal probe and water-heated pad. In order to expose the skull, the scalp was 
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incised and the periost removed. The light source, with a diameter of 2.4 mm, was 
positioned perpendicular to the skull surface within the centre of a perforated filtration 
paper that absorbed any leakage of blood. The laser beam was positioned at 2.7 mm 
anterior and 2.7 mm lateral to Bregma’s point for infarction of the frontal cortex. 
Through a cannula inside a lateral tail vein, each animal was intravenously adminis-
tered Erythrosin B (20 mg/kg) dissolved in a sterile solution of 0.9% sodium chloride 
and subjected to 0.2 μm filtration, followed by flushing with 0.9% sodium chloride to a 
total volume of 1500 μl over a 2-minute period. Then the cover of the light source 
was removed and the skull illuminated for 2.5 minutes (300 mW/cm2). In sham-
operated animals, the order of dye injection and illumination was reversed. 
Behavioural testing after surgery 
We found the animals to behave normally already a few hours after lesioning: groom-
ing, gross motor function, eating and drinking. From the first day after surgery, the 
rats were able to complete the reaction time paradigm. Thus, no recovery period was 
needed after surgery and we decided to train and test continuously. The rats were 
tested twice daily on three alternate weekdays for four weeks. Every day, the mean 
was taken from the two sessions to average out a possible bias in testing (time of 
day). Every post-lesion time-point was construed from the data of two separate days. 
To assess a general effect of the surgical procedure, in particular the influence of 
anaesthesia or the development of oedema on reaction time performance, the data 
were averaged from the first and third days after surgery or, if a weekend had 
passed, the first and fourth days after surgery (D<4). In the weeks following surgery, 
the data of four sessions collected on two days of testing were averaged every week 
(W1, W2, W3 and W4). 
Histology 
At the end of behavioural testing histology was performed on all rat brains in order to 
verify lesion volume and location. Around the lesion site, the brain was serially cut 
into 30 μm coronal sections and mounted onto slides. For the quantification of infarct 
volumes every fifth section was stained using a May-Grünwald-Giemsa protocol. The 
area and depth of the lesion were delineated in every section on a stereological mi-
croscopy set-up. Lesion volume (in mm3) was calculated by multiplying area by inter-
section thickness. 
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Statistical analyses 
All statistical analyses were done using SPSS software (version 12). Post-lesion 
performance in reaction time (RT), motor time (MT) and premature responses (PR) 
was compared to baseline performance in a between-group analysis using paired-
samples t-testing (statistical significance at p<0.05). In addition, the difference be-
tween contralesional and ipsilesional response times was deducted from their re-
spective baselines and subjected to one-sample t-testing. For certain post-lesion time 
points, analyses were performed on RT versus hold duration. This tests the effect of 
the lesion on the preparation time needed to initiate a response, also known as ex-
pectancy or anticipation. To this end, RTs were subdivided into five classes of hold 
durations, from shortest to longest hold duration: class 1 = 600/700 ms, class 2 = 
800/900 ms, class 3 = 1000/1100 ms, class 4 = 1200/1300 ms, and class 5 = 
1400/1500 ms. In addition, the total range of RTs was sorted from fastest to slowest 
reaction times and subsequently subdivided into six classes. Such an RT distribution 
analysis can be used to evaluate the role of underlying processes involved in reac-
tion time responding [34, 35]. Lesion volume was compared between groups using 
an independent-samples t-test. 
RESULTS 
Figure 2 shows histological sections of photochemically initiated infarction to the 
frontal cortex as well as the location and volume distribution of the lesions. Mean 
lesion volume did not differ significantly between groups: left frontal 1.43 mm3 (SEM 
± 0.15), and right frontal 1.29 mm3 (SEM ± 0.27); sham-operated animals were with-
out lesions. Frontal lesions were located in the rostral part of the cortical regions Fr1 
and Fr2. Most lesions were transcortical, with the corpus callosum being involved in 
one animal with a right frontal lesion. This animal was removed from statistical analy-
sis, together with two other animals that did not recover from surgery. The final num-
ber of animals per lesion group was: left frontal cortex (n=9), right frontal cortex 
(n=9), and sham-operated (n=11). No differences in body weight or task completion 
occurred during the four weeks of behavioural testing after infarction. 
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Motor times and premature responses 
Figure 3 shows the results of behavioural testing after surgery. Unilateral infarction to 
the right frontal cortex significantly decreased overall motor time at W3 and W4, and 
showed a trend towards a decrease after infarction of the left frontal cortex at W4 
(p=0.06). Motor time performance did not change following sham-operation. No dif-
ferences were observed between ipsilesional and contralesional response times in 
the frontal lesion groups. 
 The proportion of premature responses decreased primarily after sham operation 
(p<0.01 at all post-surgery time-points). Unilateral infarction to the right frontal de-
creased premature responses only at W3 and W4 (p<0.05), and showed trends to-
ward a decrease after infarction to the left frontal cortex at D7 (p=0.05) and W4 
(p=0.06). 
 
Figure 2. On left: dorsal and sagittal view of the rat brain showing the variation in lesion extent (grey circle) 
and the greatest common divisor of all lesions in a group (black circle). On right: histological sections with 
May-Grünwald-Giemsa staining showing a coronal and sagittal view of photochemically infarction to the 
frontal cortex. Frontal region: Fr 1 = frontal area 1 (or primary motor cortex), Fr2 = frontal area 2 (also 
known as medial agranular cortex). Parietal region: FL = sensorimotor area of forelimb, HL = sensorimotor 
area of hindlimb, Par1 = parietal area 1. The dorsal view was adopted from Zilles and Wree [1], the sagittal 
view from Paxinos and Watson [2]. 
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Figure 3. Effects on performance in the reaction time task in the various lesion groups: A) reaction 
times; B) motor times; C) premature responses. All values represent the difference scores between pre- 
and postoperative performance. Error bars represent the standard error of the mean. Significant differ-
ences are marked with an asterisk (*), trends with a ‘double plus’ symbol (‡). 
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Reaction times 
Figure 3a shows the reaction times after surgery. Unilateral ischemic damage to the 
left frontal cortex significantly increased overall reaction time at four weeks after 
surgery (W4). After right frontal cortex infarction, reaction time also increased but did 
not reach significance (p<0.2). Reaction time was unaltered after sham-operation. To 
investigate a possible lateralized difference in reaction time performance between left 
or right frontal cortical infarction, overall reaction times were subdivided into ipsile-
sional and contralesional response times. We found such a difference in the right 
frontal lesion group (Figure 4), where contralesional response times increased imme-
diately after surgery. A significant difference was present at two weeks (W2) after 
infarction, whereas trends were found for the first couple of days after surgery (D<4), 
and at weeks 1 and 3 (W1 and W3, respectively). 
 
 
 
Figure 4. Subdivision of reaction times into ipsilesional and contralesional responses for the left frontal 
lesion group (A) and the right frontal lesion group (B). All values represent percentage scores from baseline 
performance, which is set at 100%. Error bars represent the standard error of the mean. Significant differ-
ences are marked with an asterisk (*), trends with a ‘double plus’ symbol (‡). 
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Figure 5. Reaction time performance per class of hold duration. For lesions to the left frontal cortex bilateral 
responses are plotted against hold duration (A), and for the right frontal lesions the contralateral responses 
(B). Variable hold durations: Class 1 = 600/700 ms; Class 2 = 800/900 ms; Class 3 = 1000/1100 ms; Class 4 
= 1200/1300 ms; Class 5 = 1400/1500 ms. Error bars represent the standard error of the mean. Significant 
differences are marked with an asterisk (*). 
 
We performed two types of analyses on the reaction time data at D<4 and W4: a) 
reaction time versus hold duration; and b) reaction time distribution. For the gradual 
reaction time increase within the group of left frontal cortical lesioned animals (Figure 
5A), it was found that overall reaction times increased independently of hold duration 
at W4 (classes 1,3,4 and 5: p<0.05; class 2: p = 0.17). Furthermore, significant differ-
ences in the distribution of reaction times were found over the total range of reaction 
times at W4 (classes 1, 2, 3 and 5: p<0.05; class 4: p=0.05; class 5: p=0.06). For the 
lateralized reaction time deficit observed in the group of right frontal cortical lesioned 
animals (Figure 5B), the increase in contralesional reaction times immediately follow-
ing surgery was present primarily in trials with short hold durations of 600-900 ms (at 
D<4: class 1 p<0.01, and class 2 p<0.2; at W4: class 1 p=0.06, class 2 p=0.09, and 
classes 3 and 5 p<0.2). No significant differences were found in the distribution of 
reaction times at D<4 and W4. 
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DISCUSSION 
Aiming to model post-stroke slowing of information processing seen in humans, we 
studied the effects of unilateral infarction of the frontal cortices on reaction time per-
formance in rats. Over the course of four weeks after infarction of the left frontal cor-
tex, reaction times significantly increased whereas motor times decreased. A similar 
trend was observed after infarction of the right frontal cortex, although not significant. 
Damage to the frontal cortex thus seems to slow the motor preparatory process, 
whereas the ability to move was undisturbed. We found the increase in reaction times 
to be independent of response side or hold duration. In other words, motor readiness 
to both sides was delayed regardless of the anticipatory time given. This general 
slowing in reactivity is consistent with the role of the rat frontal cortex in the control of 
initiation and temporal organization of movement [23]. A further finding was a lateral-
ized reaction time deficit that occurred only after right frontal cortical infarction. The 
deficit occurred immediately after surgery and only in trials that required a lever press 
to the contralateral side. Both types of reaction time deficits can also be found in 
humans. First, a general disturbance in speed of information processing is observed 
in about 70% of stroke patients [4-7], particularly after frontal stroke [8, 36]. Second, 
a lateralized impairment can occur that is called neglect [37, 38], and is reflected in a 
failure to report, respond, or orient to meaningful or novel stimuli contralateral to a 
cortical lesion [39]. The failure results from an inability to integrate sensorimotor func-
tion, and is much more common and severe with right hemisphere than left hemi-
sphere lesions. 
 In human cognitive experimental psychology the use of response latency as 
main dependent variable has a long tradition [40]. An important assumption in this 
respect is that reaction time reflects information processing speed. The type of reac-
tion time testing we employed is similar to what is done in humans, and the nature of 
responding of rats in this task shows many similarities with that of humans [31]. Thus, 
reaction time as basic element of information processing is highly comparable be-
tween rats and humans. Contrary to most reaction time paradigms in rats that make 
use of lateralized visual stimulation to elicit a response, we made use of a bivalent 
auditory stimulus. It is not possible to identify which hemisphere processes the audi-
tory stimulus, but sensory information is generally processed bilaterally. However, the 
results of the present study are not confounded by a potential bias in auditory dis-
crimination as baseline performance in reaction times did not differ between re-
sponse side within groups. 
 Another important issue is that any alterations in sensory capabilities, motor 
function, or motivation can become confounding factors when measuring cognitive 
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performance [41]. Although the lack of testing primary motor and sensory capabilities 
is a limitation within our study design, we would like to stress the sensitivity of our 
reaction time paradigm in detecting minute deficits in order of milliseconds; the accu-
racy of the sampling of events in the Skinner boxes was 1 ms. Moreover, primary 
motor and sensory capabilities are unlikely to have been affected with lesions being 
located outside of the sensorimotor cortex (see Figure 2). The observed decreases in 
motor times indicate that the frontal lesions did not affect the execution of movement. 
Although this might be explained as an epiphenomenon or an effect of repeated 
training, we believe it to be compensatory to the increase in reaction time: when 
maximally prepared, impairment of the motor initiation process may result in in-
creased motor execution. Furthermore, since the proportion of premature responses 
hardly changed after frontal cortex infarction, the increase in reaction times is not 
likely to be caused by a decrease in response inhibition. 
 What could be the nature of the observed reaction time deficits? Theoretically, 
deficits in reactivity can be caused by a disability to initiate a motor response or by a 
disruption of attentional processes, or both. In general, a hold duration-dependent 
increase in reaction time is interpreted as a disability to prepare the initiation of a 
motor response [10, 20], whereas an increase in the variation of reaction time distri-
bution has been associated with a decrease in attentional processes related to the 
preparation of movement [34, 35]. As our analysis of reaction time distribution shows, 
a disturbance of attentional function could have caused the general slowing in reac-
tivity after left frontal infarction. On the other hand, the lateralized impairment ob-
served immediately after right frontal infarction, may be related to a disability in pre-
paring movement initiation under the pressure of time. 
 How can these reaction time deficits be explained? The origin of the lateralized 
reaction time deficit almost definitely lies within the frontal cortex, since it emerged 
immediately following surgery. By contrast, the general slowing in reactivity may be 
the result of either degenerative or plastic changes within the cerebral cortex or sub-
cortical areas. The frontal lobes have been shown to play a critical role in intentional 
(or motor) systems [42, 43]. Unilateral lesions of the frontal cortices are known to 
cause a contralateral ‘neglect’ in both rats and primates. This inability to respond to 
stimuli in contralateral space can be interpreted as either reflecting attentional or 
representational neglect [42] or, alternatively, an intentional or ‘output’ form of neglect 
[43]. A putative circuit for directing spatial attention has been identified [44, 45], which 
is equivalent to the distributed cortical attentional system proposed in primates [46]. 
The circuit in the rat is thought to involve medial agranular cortex (Fr2), ventrolateral 
orbital (Fr1) and posterior parietal cortex (Par1). In addition, changes in neurotrans-
mitter function might explain both the biochemical and behavioural findings observed 
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after cortical lesions [26, 47, 48]. A recent report covering 20 years of research using 
a rat model of contralateral neglect [49], explains the neurobiology of this phenome-
non as an acute loss of dopaminergic input to the dorsocentral striatum showing 
recovery with dopaminergic agonists. The lateralized deficit in movement initiation we 
observed may thus be caused by dysfunction of the dopaminergic system. Further-
more, the general slowing in reactivity might be related to degeneration and subse-
quent plastic changes within the basal forebrain cholinergic system, which is known 
to influence attentional function and optimize cortical information processing [50]. 
 In conclusion, two types of reaction time deficits were observed after unilateral 
infarction to the frontal cortices in rats. Infarction to the left frontal cortex of rats in-
duced a general slowing in reactivity similar to the mental slowing observed in stroke 
patients, whereas a lateralized deficit showing right hemispheric dominance was 
observed that resembles left-sided neglect in humans. We hypothesize the former 
may be related to a decrease in either attentional function or speed of information 
processing following plastic changes within the cholinergic basal forebrain system, 
whereas the latter may be due to impairment of motor initiation caused by an imme-
diate loss of dopaminergic input to the dorsocentral striatum. Measuring reaction time 
performance after cortical infarction in rats could offer a useful tool to model human 
post-stroke cognitive impairment. 
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ABSTRACT 
The syndrome of hemispatial neglect is defined as an inability to report, respond or 
orient to stimuli contralateral to a cerebral lesion despite intact elementary sensory or 
motor function. This syndrome is typically observed after lesions of the right cerebral 
cortex, and has been associated with impairment of attention. We studied whether 
visual attention performance is impaired after right hemisphere infarction in rats. 
Using a behavioural paradigm measuring spatial visual attention, we tested the ef-
fects of photothrombotic infarction to either the frontal cortex or the parietal cortex on 
attention performance. Since the cholinergic system is known to modulate attention 
performance, we additionally evaluated the role of cholinergic receptor blockade with 
scopolamine in our task paradigm. Our results show a transient response bias imme-
diately after cortical infarction, with a decrease in contralesional responses and an 
increase in contralesional omissions after frontal infarction. Parietal infarction and 
systemic administration of scopolamine also resulted in a decrease in correct re-
sponses and an increase in omissions, but without a difference in side responding. In 
conclusion, right frontal infarction induces a transient impairment in contralesional 
spatial visual attention that we explain as left-sided neglect. Right parietal infarction 
and cholinergic blockade shows non-lateralized deficits in spatial visual attention, 
suggestive of global attentional impairment. We postulate that both effects of cortical 
infarction on attention performance may be related to cholinergic dysfunction. Our 
study confirms the role of frontal and parietal cortices in attention performance in rats, 
and corroborates the theory that attention performance is impaired in hemispatial 
neglect in human stroke patients. 
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INTRODUCTION 
The syndrome of hemispatial neglect is defined as an inability to report, respond or 
orient to stimuli contralateral to a cerebral lesion despite intact elementary sensory or 
motor function [3]. This syndrome is typically observed in stroke patients, and is more 
common and severe after lesions in the right hemisphere compared to the left hemi-
sphere. The inability to respond most likely originates from a failure to integrate sen-
sorimotor function. Phenomena associated with the neglect syndrome can be subdi-
vided into three major categories: representational deficits, action-intentional disor-
ders (‘motor neglect’) and hemi-inattention (‘sensory neglect’) [4]. Using a reaction 
time task, we previously compared the effects of left frontal cortex infarction to right 
frontal cortex infarction in rats [5]. We observed a form of motor neglect that occurred 
only after right frontal cortical infarction. However, fundamental to cognitive informa-
tion processing are mechanisms of attention. Disturbances in attention have been 
associated with the neglect syndrome in humans [6]. 
 Mesulam introduced the concept of the right hemisphere cortical attentional 
system [7], which may explain the occurrence of attention deficits in the neglect syn-
drome. Herein, the right cerebral hemisphere is considered dominant for spatial vis-
ual attention through a cortical network that surveys both sides of personal and ex-
trapersonal space. This neuronal network allows for the narrowing of the attentional 
focus on motivationally relevant spatial stimuli. Additionally, the right hemisphere is 
involved in non-spatially sustained attention [8], which has also been shown to be 
impaired in hemispatial neglect [9-11]. Right frontal and parietal cortical regions ap-
pear particularly important for maintaining spatial attention in humans [12]. A putative 
circuit for directing spatial attention has also been identified in rodents, involving the 
medial frontal cortex, posterior parietal cortex and dorsolateral striatum [13-15]. 
 Lateralized deficits in visual attention performance may alternatively be caused 
by dysfunction of neurotransmitter-specific networks [16, 17]. The basal forebrain 
cholinergic system is known to modulate attention performance by optimizing cortical 
information processing [18-20]. Several studies have implicated cholinergic projec-
tions to the cortex in visual attention performance in the rat [21-27]. Interestingly, 
lateralized attentional functions of these cortical cholinergic inputs have been de-
scribed following unilateral damage to their cells of origin within the basal forebrain 
[17, 28]. It is hypothesized that right-hemisphere cortical inputs mediate signal detec-
tion processes of right-hemisphere attention systems, whereas left-hemisphere corti-
cal inputs are involved in executive aspects of attention performance by left-
hemisphere circuits. Thus, loss of right-hemisphere cholinergic function may explain 
the occurrence of left-sided visual spatial neglect. 
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As mentioned above, hemispatial neglect originates from a failure to integrate sen-
sorimotor function along a spectrum of motor neglect and sensory neglect. The pre-
sent study investigates whether impairment of attention performance occurs after 
right hemisphere infarction in rats. We aimed to determine the contribution of a pos-
sible attentional impairment to the neglect phenomenon observed previously after 
right frontal cortical infarction [5]. Using a behavioural paradigm measuring spatial 
visual attention, we tested the effects of infarction to either the frontal cortex or the 
parietal cortex of the right hemisphere. Furthermore, to evaluate the role of choliner-
gic function on attention performance in the behavioural paradigm, we tested spatial 
visual attention in a group of non-lesioned animals with and without administration of 
scopolamine, a muscarinic acetylcholine receptor antagonist. 
MATERIALS AND METHODS 
Subjects 
All experimental procedures were approved by the local ethical committee for animal 
experiments at Maastricht University and met governmental guidelines. Forty male 
Lewis rats served as subjects in this study. They were housed individually in standard 
type III Makrolon cages, on sawdust bedding in an air-conditioned room of about 
21°C with 45-55% humidity under a reversed light/dark cycle (lights on from 7 p.m. to 
7 a.m.) and had ad libitum access to water. To prevent a motivational bias during 
behavioural testing, the rats were food-restricted and given 12-14 g laboratory chow 
per day. In the weekends, the rats had ad libitum access to food up until 12 hours 
prior to testing. In doing so, the weight of the animals was kept at 85% of a freely-fed 
reference group. 
Experimental design 
Rats were trained in a behavioural paradigm measuring spatial visual attention, as 
described previously [29]. We performed two types of experiments. One experiment 
tested attention performance after frontal cortex infarction (n=10), parietal cortex 
infarction (n=10), and in sham-operated animals (n=10) (Experiment I). Since neglect 
phenomena are primarily observed after right-sided brain damage in humans, lesions 
were induced in the right hemisphere. Another experiment tested the effects of mus-
carinic acetylcholine receptor blockade on task performance in a group of non-
lesioned animals (n=10) (Experiment II). These rats were tested after intraperitoneal 
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administration of scopolamine hydrochloride (Sigma Aldrich) 0.1 mg/kg, 0.3 mg/kg or 
vehicle (sterile saline). 
Behavioural procedures 
Apparatus 
Spatial visual attention performance was trained and tested in ten identical Skinner 
boxes (40x30x33 cm). The ceiling of these conditioning chambers contained a light 
that illuminated the conditioning chamber during experiments. The left and right 
sidewalls served as control panels. A recess (5x5 cm), built into the left side panel 
2.5 cm above the grid floor, contained a food tray into which a pellet dispenser deliv-
ered 45-mg food pellets (Bioserve, Frenchtown, NJ, USA). Two retractable stainless 
steel levers (4 cm wide) projected 2 cm into the conditioning chamber and were lo-
cated 6 cm from both sides of the recess, 12 cm above the grid floor. The condition-
ing chambers were enclosed in sound-attenuating housing. Background noise was 
produced by a radio and an exhaust fan. A personal computer controlled the experi-
mental equipment and collected the data. 
 
Spatial visual attention task 
The rats first underwent a magazine training. In this training about 30 food pellets 
were randomly supplied during a period of 15 minutes; all food pellets were con-
sumed. The levers were retracted from the operant conditioning chamber during this 
phase. After completion of this training, the rats underwent a Continuous Reinforce-
ment (CRF) training schedule. In this CRF training, either the right or left lever was 
presented at random, but both with the same number of times per session. As soon 
as the rat pressed a lever, it was retracted and a food pellet was delivered. After the 
rat had taken the food pellet from the tray, there was an inter-trial interval of 5 sec-
onds. Then the next trial was started by insertion of a lever into the Skinner box. A 
total of 80 food pellets could be obtained in a session lasting a maximum of 40 min. 
Generally, the rats completed the session within 20 min, in which all food pellets were 
consumed. Qualitative observations indicated that the rats were facing the front of the 
Skinner box wall with their nose headed towards the centre of the wall each time a 
trial started. Previous studies have shown that the rats only miss one or two trials per 
session, indicating that they are actively engaged in the task [29, 30]. 
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In the behavioural test paradigm (Figure 1), a light stimulus was presented either on 
the left side or on the right side of the food reward tray. The duration of the light 
stimulus varied randomly between 3, 1 and 0.3 seconds. One second after the light 
stimulus was extinguished, the two levers were inserted simultaneously. When the rat 
hit the lever on the side of the prior light stimulus (correct response), the rat was 
rewarded with a food pellet followed by an inter trial interval (ITI) of 5 to 10 seconds. 
When the rat hit the lever on the opposite side of the previous light stimulus (incorrect 
response), the rat was not rewarded. After a time-out period of 5 seconds was fol-
lowed by an ITI. When the rat did not hit a lever within 3 seconds (omission), the rat 
was not rewarded and both levers were retracted followed by a time-out period of 5 
seconds and an ITI. A total of 80 food pellets could be obtained during a session 
lasting a maximum of 20 min. 
Figure 1. Schematic representation of the behavioural paradigm, showing the operating wall of the 
Skinner box (top) and the series of stages in the spatial visual attention task. 
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The main behavioural measures derived from this task were as follows: 
 
1) Index Y: a signal detection measure for response bias. It was calculated as the 
 absolute value of Percentage correct left –  Percentage correct right
Percentage correct left  Percentage correct right+  
 This measure determined whether the rats develop a preference to respond to 
 one side. A value of zero would indicate that there was no side bias, whereas a 
 value of 1 indicated that the rats respond to one side only [31]. With absolute 
 values between 0 and 1, index Y does not discriminate between left-sided and 
 right-sided response biases. 
2)  Percentage Correct: Correct responses
Total number of trials –  Omissions
 
 To detect response side bias, the percentage of correct responses was subdivided 
into right-sided and left-sided responses. 
 
3)  Omissions: total number of times the rat did not hit either lever within the re-
 quired time. To detect response side bias, the number of omissions was subdi-i
 vided into right-sided and left-sided response failures. 
 
Rats were trained in the behavioural paradigm with two sessions daily until stable 
performance was achieved (no improvement on five successive training sessions). 
Experiment I – visual attention after cortical infarction 
Body weight and task performance were matched between experimental groups prior 
to surgery. Anaesthesia was induced by inhalation of halothane 4% and maintained 
with halothane 1% and a mixture of O2/N2O (1:2) in spontaneously breathing rats. As 
described previously [32], cortical infarction was induced by photochemically initiated 
thrombosis through intravenous injection of the light-sensitive dye Erythrosin B 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) and illumination of the skull with a 
monochromatic light source (DPSS laser, Uniphase, Germany). The light source, with 
a diameter of 2.4 mm, was positioned perpendicular to the skull surface in the centre 
of a perforated filtration paper that absorbed any leakage of blood; its beam was 
positioned at 2.7 mm anterior and 2.7 mm lateral to Bregma’s point for infarction of 
the frontal cortex, and at 2.7 mm posterior and 5.4 mm lateral to Bregma’s point for 
infarction of the parietal cortex. In sham-operated animals, the order of dye injection 
and illumination was reversed. 
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We found the animals to behave normally already a few hours after cortical infarction: 
grooming, gross motor function, eating, and drinking. From the first day after surgery, 
the rats were able to respond in the Skinner box task and to complete the training 
session (80 trials within 20 min), which was similar to the performance prior to sur-
gery. Thus, no recovery period was needed after surgery and rats were trained and 
tested continuously twice daily on three alternate weekdays for three weeks. 
 At the end of behavioural testing, histology was performed on all rat brains in 
order to verify lesion volume and location. Around the lesion site, the brain was seri-
ally cut into 30-μm coronal sections and mounted onto slides. For the quantification 
of infarct volumes, every fifth section was stained using a May–Grünwald–Giemsa 
protocol [33]. The area and depth of the lesion were delineated in each section on a 
stereological microscopy set-up. Lesion volume (in mm3) was calculated by multiply-
ing lesion area by intersection thickness. 
Experiment II – visual attention after cholinergic blockade 
Task performance was tested during two sessions on the same day 30 minutes after 
intraperitoneal injection of either vehicle solution (1 ml of sterile saline) or scopola-
mine 0.1 mg/kg dissolved in 1 ml vehicle solution. Two days later, task performance 
was re-tested 30 minutes after injection of either 1 ml vehicle solution or scopolamine 
0.3 mg/kg dissolved in 1 ml vehicle solution. The data after vehicle injection were 
averaged to serve as control (baseline data). 
Data processing and statistical analyses 
All statistical analyses were done using SPSS software (version 12). Group differ-
ences in lesion volume and body weight were compared using Student’s t-testing 
(two-tailed, independent samples). In Experiment I, baseline-data were obtained by 
averaging the last four test sessions prior to the induction of cortical infarction. Fol-
low-up data were averaged across two sessions acquired on days 1 and 3, and if a 
weekend had passed on days 1 and 4 after surgery (D4). In the weeks following 
surgery, data were averaged of days 6 and 8 (W1), days 13 and 15 (W2), and days 
20 and 22 (W3). Data of Experiment I were analyzed using a three-way ANOVA 
(Lesion group as between subjects factor; Time and Side of response as within sub-
jects factors). Differences between conditions were evaluated using an LSD post hoc 
test. To test for lateralized responding, ipsilesional performance was deducted from 
contralesional performance and subjected to a one-sample ANOVA. In Experiment II, 
vehicle injection data were averaged to serve as baseline. The effects of scopola-
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mine were tested using a two-way ANOVA (Dose and Stimulus duration as within 
subjects factor). To evaluate possible side differences in responding, we evaluated 
left and right sided responses at the shortest stimulus duration using a one-way 
ANOVA (Side of response as within subjects factor).  
RESULTS 
Experiment I - visual attention after cortical infarction 
Lesion group characteristics 
Figure 2 shows the location and volume of cortical infarction. Parietal lesions were 
located in the primary sensorimotor cortex (Par1), also known as posterior parietal 
cortex. Frontal lesions were located in the rostral part of the cortical premotor areas 
Fr1 and Fr2, respectively known as the lateral frontal cortex and medial frontal cortex. 
Five animals were excluded from statistical analysis. 
 
 
Figure 2. On left: dorsal and sagittal view of the rat brain showing the variation in lesion extent (grey 
circle) and the greatest common divisor of all lesions within an experimental group (black circle). On 
right: coronal sections with May-Grünwald-Giemsa staining showing phototrombotic infarction to the 
frontal and parietal cortices. Frontal region: Fr 1 = frontal area 1 (or primary motor cortex), Fr2 = frontal 
area 2 (also known as medial agranular cortex). Parietal region: FL = sensorimotor area of forelimb, HL 
= sensorimotor area of hind limb, Par1 = parietal area 1 (or primary somatosensory cortex). The dorsal 
view was adopted from Zilles and Wree [1], the sagittal view from Paxinos and Watson [2]. 
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One animal was unable to master the behavioural task adequately, two animals died 
during surgical procedures (anaesthesia), and another two animals were excluded 
from analysis because at post-mortem examination of the brain no lesion could be 
detected. Therefore, the final number of animals group was: right frontal cortex (n=9), 
right parietal cortex (n=7), and sham-operated (n=9). Mean lesion volume at the end 
of behavioural testing was greater for right frontal infarction (1.76 ± 0.24 mm3) as 
compared with right parietal infarction (1.22 ± 0.20 mm3) of the cerebral cortex 
(t(14)=2.93, p<0.05). No lesions were detected in sham-operated animals. No differ-
ences in body weight were found between groups during the four weeks of behav-
ioural testing after infarction. 
 
Spatial visual attention after cortical infarction 
Figures 3 and 4 summarize the results after cortical infarction. At the longer stimulus 
durations of 1 and 3 seconds, no group differences were observed for the behav-
ioural parameters (all F’s<1.3, ns). Consequently, we decided to only evaluate lesion 
effects at the shortest stimulus duration of 300 ms. This dependency on stimulus 
duration indicates that attention performance was related to task difficulty and atten-
tional load rather than an inability to complete the task. Changes in spatial visual 
attention were observed only within the lesion groups and not after sham operation, 
which shows that performance was not disturbed by the surgical procedures, in par-
ticular anaesthesia. Inspection of the data revealed that effects occurred only in the 
first days after cortical infarction (D4) and had disappeared after one week (W1). 
Therefore, we evaluated lesion effects by analyzing performance for the first three 
time points (Baseline, D4 and W1). 
 
Figure 3. Response side bias in the spatial visual attention task. Left graph shows index Y in Experi-
ment I for the shortest stimulus duration. Right graph shows index Y in Experiment II. Error bars repre-
sent the standard error of the mean. Post hoc analyses: (*) significant difference between groups. 
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Figure 4. Percentage correct responses and number of omissions subdivided into ipsilateral and contra-
lateral side responses for sham-operated animals, right frontal lesion group, and right parietal lesion 
group. For the percentage of correct responses, all values represent percentage scores from baseline 
performance (set at 100%). The number of omissions is an absolute value. Error bars represent the 
standard error of the mean. Post hoc analyses: (*) significant difference between groups (p<0.05); (‡) 
significant difference within groups (p<0.05). 
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For index Y, we found a clear effect of Time (F(2,44)=9.48, p<0.01) that tended to be 
different for the lesion groups (F(2,44)=2.29, p<0.08). Evaluation of the effect of Time 
within each group showed that index Y was affected after frontal (F(2,16)=3.75, 
p<0.05) and parietal infarction (F(2,12)=5.64, p<0.05) and not after sham operation 
(F(2,16)=0.08, ns). Post hoc analysis revealed that both lesion groups differed from 
the sham group at D4, and the lesion effect was similar after frontal and parietal 
infarction. 
 For Percentage Correct, a Lesion by Time by Side interaction effect was found 
(F(4,44)=3.80, p<0.05; see Figure 4). Analysis within groups did not reveal Time, 
Side, and Time by Side interaction effects in the sham group (all F’s<1.67, ns), indi-
cating that surgery did not affect the performance of these animals. Clear Time by 
Side interaction effects were found in the frontal lesion group (F(2,16)=17.41, p<0.01) 
as well as the parietal lesion group (F(2,14)=7.33, p<0.01). Inspection of Figure 4 
shows that these effects were related to changes in performance contralateral to the 
lesion whereas ipsilateral performance was unaltered. Post hoc analysis showed that 
contralateral performance did not change after sham operation, and differed signifi-
cantly at D4 and W1 for the frontal lesion group and at W1 for the parietal lesion 
group. 
 For the measure Omissions, a clear effect of Time was found (F(2,44)=9.48, 
p<0.01). Within group analysis showed that there was no effect of Time in the sham 
group (F(2,16)=1.06, ns), whereas Time effects were present in the frontal 
(F(2,16)=3.75, p<0.05) and parietal groups (F(2,12)=5.64, p<0.05). Furthermore, a 
marginal Time by Side interaction effect was observed (F(4,44)=2.29, p<0.07). 
Analysis within groups showed that the Side by Time interaction effect occurred only 
in the frontal lesion group (F(2,16=4.14, p<0.05), and not in the parietal lesion and 
sham operation group (F’s<1, ns). 
Experiment II - visual attention after cholinergic blockade 
Figures 3 and 5 show spatial visual attention task performance with or without ad-
ministration of scopolamine. The measure index Y for side bias increased with dose 
of scopolamine (F(2,27)=5.49, p<0.05) and shorter stimulus durations 
(F(2,54)=17.77, p<0.01). The effect of scopolamine was independent of stimulus 
duration (F(4,54)=0.74, ns). A similar result was found for the percentage of correct 
responses as we found a clear decrease in percentage correct responses as a func-
tion of increasing dose of scopolamine (F(2,27)=11.84, p<0.01), and shorter stimulus 
durations (F(2,54)=48.42, p<0.01). The effect of scopolamine was independent of 
stimulus duration (F(4,54)=0.08, ns). 
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Figure 5. Percentage correct responses and number of omissions subdivided into right-sided and left-
sided responses after cholinergic muscarinic receptor blockade with sterile saline (vehicle), scopolamine 
0.1 mg/kg (scopo 0.1), and scopolamine 0.3 mg/kg (scopo 0.3). Error bars represent the standard error 
of the mean. Post hoc analyses: (*) significant difference between groups (p<0.05). 
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Post hoc analysis revealed that performance at the highest dose (scopolamine 0.3 
mg/kg) differed from the other two conditions (vehicle and scopolamine 0.1 mg/kg) for 
all stimulus durations. No differences occurred in responding towards the left or right 
side. At the shortest stimulus duration, the percentage of correct responses was 
equal to both sides (F(1,29)=0.47, ns). The number of omissions increased with dose 
of scopolamine (F(2,29)=27.59, p<0.01). Post hoc analysis showed that scopolamine 
0.3 mg/kg differed from both vehicle solution and scopolamine 0.1 mg/kg, whereas 
no difference was found between vehicle and scopolamine 0.1 mg/kg. No significant 
effects of Side were found after scopolamine treatment. At the shortest stimulus 
duration condition, the number of omissions was equal to both sides (F(1,29)=3.00, 
ns). 
DISCUSSION 
The aim of the present study was to investigate the effects of right hemisphere corti-
cal infarction on attention performance in the rat. To this end, we trained rats in a 
behavioural task assessing spatial visual attention, and tested performance after 
infarction to either the right frontal cortex or right parietal cortex. The main objective 
was to determine the contribution of a possible attentional impairment to the neglect 
phenomenon observed previously following cerebral infarction [5]. A secondary ob-
jective was to evaluate to the effect of blockade of cholinergic function within our task 
paradigm. 
 Our results show a response bias shortly after infarction to frontal and parietal 
cortices of the right hemisphere (see Figure 3). This effect was transient, since the 
most pronounced effects were found within the first 4 days after surgery (D4). The 
percentage of correct responses decreased together with an increased number of 
omissions, in particular for left-sided trials after right frontal cortex infarction (see 
Figure 4). The effects of infarction were found only at the shortest stimulus duration, 
indicating that the observed deficit is related to task difficulty and dependent on atten-
tional load. Furthermore, changes were observed only in the lesion groups and not 
after sham operation, which shows that performance was not disturbed by the surgi-
cal procedures such as anaesthesia. The deficits in attention performance appeared 
to be a transient phenomenon, since behavioural performance had returned to base-
line levels one week after surgery. Deficits in attention performance were also found 
after muscarinic acetylcholine receptor blockade (Figures 3 and 5). Following sys-
temic administration of scopolamine, response bias also increased together with a 
decreased percentage of correct responses and an increased number of omissions. 
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No differences occurred in responding towards the left or right side. We explain this 
non-lateralized response bias as a global non-lateralized attentional deficit. 
 It is tempting to compare the effects of frontal infarction with parietal infarction. 
First of all it should be noted that direct comparison of potentially dissociable effects 
of lesion location may be limited by the significant difference in infarct size at the 
expense of parietal infarction, which was caused by thicker bone of the frontal skull 
and the attachment of the masseter muscle hindering adequate positioning of the 
laser beam over the posterior parietal cortex [unpublished observations]. Second, 
caution should be exercised with making inferences from the figures, as there was no 
significant difference between lesion groups for index Y. Nonetheless, Figure 3 
seems to indicate a greater degree of response bias in the parietal lesion group at 
D4, whereas the decrease in contralateral responses is more pronounced in the 
frontal lesion group. This apparent paradox is likely due to averaging of individual 
data since the standard error for index Y is much larger for the parietal lesion group. 
Another striking feature after parietal infarction is the greater number of omissions 
compared to frontal infarction, which was equal for both ipsilateral and contralateral 
omissions. Since a non-lateralized increase in omissions was also observed after 
scopolamine administration, this may suggest a global attentional deficit related to 
cholinergic dysfunction following parietal infarction. With regard to hemispatial ne-
glect in humans, parietal infarction in rats may thus induce deficits in non-spatially 
sustained attention [9, 34]. By contrast, frontal infarction resulted predominantly in a 
lateralized, contralesional attention deficit. We explain this as an attentional impair-
ment for the left visual field, which is in accordance with the most prevalent form of 
neglect following right hemisphere damage. It remains speculatory whether this ne-
glect phenomenon involves cholinergic function. Finally, the increase in contralateral 
correct responses in both lesion groups one week after lesioning (W1) suggests a 
kind of rebound phenomenon. At this post-lesion time-point, however, neither re-
sponse bias nor the number of omissions was altered. 
 Phenomena associated with neglect can be interpreted along the spectrum of 
sensorimotor integration as either reflecting deficits in attentional performance (‘sen-
sory neglect’) versus intentional performance (‘motor neglect’) [35, 36]. In accordance 
with the latter, we previously reported on a form of motor neglect that lasted for three 
weeks [5]. We attributed this to impairment of movement initiation that relates well 
with the functional role of the rat frontal cortex [37]. The present study indicates that 
the neglect phenomenon after right frontal infarction harbours an attentional compo-
nent lasting for a few days. A similar short-term effect on attention performance has 
also been reported following left-hemisphere aspirative lesions of the frontal cortex 
[38], and may be explained by a transient disturbance in neurotransmitter function.. 
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We postulate that the type of visual neglect observed in this study may be caused by 
a transient disturbance of cholinergic tone within the right hemisphere. As mentioned 
above, our results do not prove a direct relation between left-sided neglect and cho-
linergic dysfunction. Prove would require additional experimentation, for instance with 
direct cortical injection of muscarinic acetylcholine receptor antagonists. All in all, our 
results clearly show impaired spatial visual attention after cortical infarction as well as 
after cholinergic blockade. 
 In conclusion, we compared spatial visual attention performance after right fron-
tal cortex infarction and right parietal cortex in rat brain. Immediately after frontal 
infarction, a transient impairment in spatial attention of the visual field contralateral to 
the lesion was observed. We explain this inability as left-sided visual neglect, which 
may be attributed to impairment of the cortical brain circuitry involved in the process-
ing of attention. Both after parietal infarction and cholinergic blockade with scopola-
mine, a global attentional deficit occurred. We postulate that dysfunction of the cho-
linergic system may be related to the observed impairments in spatial visual atten-
tion. Our study confirms the role of the parietal and frontal cortices of the rat in atten-
tion performance, and corroborates the theory that attention performance is impaired 
in left-sided visual neglect in human stroke patients. 
Spatial visual attention performance afer cortical infarction  
 67 
REFERENCES 
1. Zilles K, Wree A. Cortex: areal and laminar structure. In: Paxinos G, editor. The Rat Nervous System. 
San Diego: Academic Press; 1995. p. 649-85. 
2. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edition ed. New York: Academic 
Press; 1998. 
3. Heilman KM, Valenstein E, Watson RT. Neglect and related disorders. Semin Neurol. 2000;20(4):463-
70. 
4. Swan L. Unilateral spatial neglect. Phys Ther. 2001 Sep;81(9):1572-80. 
5. Hoff EI, Blokland A, Rutten K, Steinbusch HW, van Oostenbrugge RJ. Dissociable effects in reaction 
time performance after unilateral cerebral infarction: a comparison between the left and right frontal cor-
tices in rats. Brain Res. 2006 Jan 19;1069(1):182-9. 
6. Cherney LR. Unilateral neglect: a disorder of attention. Semin Speech Lang. 2002 May;23(2):117-28. 
7. Mesulam MM. A cortical network for directed attention and unilateral neglect. Ann Neurol. 1981 
Oct;10(4):309-25. 
8. Nachev P, Husain M. Disorders of visual attention and the posterior parietal cortex. Cortex. 2006 
Jul;42(5):766-73. 
9. Husain M, Rorden C. Non-spatially lateralized mechanisms in hemispatial neglect. Nat Rev Neurosci. 
2003 Jan;4(1):26-36. 
10. Milner AD, McIntosh RD. The neurological basis of visual neglect. Curr Opin Neurol. 2005 
Dec;18(6):748-53. 
11. Corbetta M, Kincade MJ, Lewis C, Snyder AZ, Sapir A. Neural basis and recovery of spatial attention 
deficits in spatial neglect. Nat Neurosci. 2005 Nov;8(11):1603-10. 
12. Mesulam MM. Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental 
representation and attentional targeting of salient extrapersonal events. Philos Trans R Soc Lond B Biol 
Sci. 1999 Jul 29;354(1387):1325-46. 
13. King VR, Corwin JV. Comparisons of hemi-inattention produced by unilateral lesions of the posterior 
parietal cortex or medial agranular prefrontal cortex in rats: neglect, extinction, and the role of stimulus 
distance. Behav Brain Res. 1993 Apr 30;54(2):117-31. 
14. Muir JL, Everitt BJ, Robbins TW. The cerebral cortex of the rat and visual attentional function: dissoci-
able effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice 
serial reaction time task. Cereb Cortex. 1996 May-Jun;6(3):470-81. 
15. Reep RL, Corwin JV, Cheatwood JL, Van Vleet TM, Heilman KM, Watson RT. A rodent model for 
investigating the neurobiology of contralateral neglect. Cogn Behav Neurol. 2004 Dec;17(4):191-4. 
16. Apicella P, Legallet E, Nieoullon A, Trouche E. Neglect of contralateral visual stimuli in monkeys with 
unilateral striatal dopamine depletion. Behav Brain Res. 1991 Dec 20;46(2):187-95. 
17. Bushnell PJ, Chiba AA, Oshiro WM. Effects of unilateral removal of basal forebrain cholinergic neurons 
on cued target detection in rats. Behav Brain Res. 1998 Jan;90(1):57-71. 
18. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol. 1997;48:649-84. 
19. Baxter MG, Chiba AA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol. 1999 
Apr;9(2):178-83. 
20. Sarter M, Givens B, Bruno JP. The cognitive neuroscience of sustained attention: where top-down 
meets bottom-up. Brain Res Brain Res Rev. 2001 Apr;35(2):146-60. 
21. Robbins TW, Everitt BJ, Marston HM, Wilkinson J, Jones GH, Page KJ. Comparative effects of ibotenic 
acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: 
further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. 
Behav Brain Res. 1989 Dec 1;35(3):221-40. 
 Chapter 4 
 68 
22. Muir JL, Dunnett SB, Robbins TW, Everitt BJ. Attentional functions of the forebrain cholinergic systems: 
effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts 
on a multiple-choice serial reaction time task. Exp Brain Res. 1992;89(3):611-22. 
23. Muir JL, Everitt BJ, Robbins TW. AMPA-induced excitotoxic lesions of the basal forebrain: a significant 
role for the cortical cholinergic system in attentional function. J Neurosci. 1994 Apr;14(4):2313-26. 
24. Muir JL, Everitt BJ, Robbins TW. Reversal of visual attentional dysfunction following lesions of the 
cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, on-
dansetron. Psychopharmacology (Berl). 1995 Mar;118(1):82-92. 
25. Phillips JM, McAlonan K, Robb WG, Brown VJ. Cholinergic neurotransmission influences covert orienta-
tion of visuospatial attention in the rat. Psychopharmacology (Berl). 2000 May;150(1):112-6. 
26. Gill TM, Sarter M, Givens B. Sustained visual attention performance-associated prefrontal neuronal 
activity: evidence for cholinergic modulation. J Neurosci. 2000 Jun 15;20(12):4745-57. 
27. Himmelheber AM, Sarter M, Bruno JP. Increases in cortical acetylcholine release during sustained 
attention performance in rats. Brain Res Cogn Brain Res. 2000 Jun;9(3):313-25. 
28. Martinez V, Sarter M. Lateralized attentional functions of cortical cholinergic inputs. Behav Neurosci. 
2004 Oct;118(5):984-91. 
29. Blokland A, Lieben C, Deutz NE. Anxiogenic and depressive-like effects, but no cognitive deficits, after 
repeated moderate tryptophan depletion in the rat. J Psychopharmacol. 2002 Mar;16(1):39-49. 
30. Klapdor K, Blokland A, Horvath E, van der Staay FJ. Bilateral subdural hematoma in the rat: effects on 
performance in a visual discrimination task. Neurosci Res Comm. 1997;20(2):79-84. 
31. Sahgal A. Some limitations of indices derived from signal detection theory: evaluation of an alternative 
index for measuring bias in memory tasks. Psychopharmacology (Berl). 1987;91(4):517-20. 
32. Hoff EI, Oude Egbrink MG, Heijnen VV, Steinbusch HW, van Oostenbrugge RJ. In vivo visualization of 
vascular leakage in photochemically induced cortical infarction. J Neurosci Methods. 2005 Jan 
30;141(1):135-41. 
33. Vacca LL. Laboratory manual of histochemistry. New York: Raven Press; 1985. 
34. Corbetta M, Kincade JM, Shulman GL. Neural systems for visual orienting and their relationships to 
spatial working memory. J Cogn Neurosci. 2002 Apr 1;14(3):508-23. 
35. Kirk A. Spatial neglect. Curr Neurol Neurosci Rep. 2001 Nov;1(6):541-6. 
36. Heilman KM. Intentional neglect. Front Biosci. 2004 Jan 1;9:694-705. 
37. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. 1984 Nov;320(1):65-
98. 
38. Crowne DP, Pathria MN. Some attentional effects of unilateral frontal lesions in the rat. Behav Brain 
Res. 1982 Sep;6(1):25-39. 
 69 
Chapter 
Pharmacological magnetic 
resonance imaging of muscarinic 
acetylcholine receptor activation in 
rat brain 
 
 
 
Erik I. Hoff 
Robert J. van Oostenbrugge 
Wim M. Otte 
Ona Wu 
Harry W.M. Steinbusch 
Rick M. Dijkhuizen 
 
Submitted 
 Chapter 5 
 70 
ABSTRACT 
The central cholinergic system is involved in several cognitive functions such as 
attention, consciousness, learning and memory. Functional imaging of this neuro-
transmitter system may provide novel opportunities in the diagnosis and evaluation of 
cognitive disorders. The aim of this study was to investigate the spatial and temporal 
activation patterns of muscarinic acetylcholine receptor (mAChR) stimulation in rat 
brain with pharmacological magnetic resonance imaging (phMRI). We performed 
blood oxygenation level-dependent (BOLD) MRI and contrast-enhanced cerebral 
blood volume (CBV)-weighted MRI combined with injection of pilocarpine, a non-
selective mAChR agonist, or injection of vehicle solution. BOLD and CBV responses 
were assessed after pretreatment with methyl-scopolamine in order to block periph-
eral muscarinic effects. Region-of-interest analysis in individual animals and group-
level Independent Component Analysis showed that pilocarpine induced significant 
BOLD signal increases primarily in the cerebral cortex. With contrast-enhanced CBV-
weighted MRI, positive CBV responses were detected in the cerebral cortex, thala-
mus, and hippocampus whereas a negative CBV response was observed in the 
striatum. Thus, pilocarpine induced significant activation responses in brain regions 
that are known to have a high density of muscarinic receptors. Our study demon-
strates that phMRI of mAChR stimulation in rats allows functional assessment of the 
cholinergic system in vivo. 
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INTRODUCTION 
Functional magnetic resonance imaging (fMRI) provides a means to assess brain 
activity in vivo. Pharmacological MRI (phMRI) is a variant of fMRI that allows meas-
urement of cerebral activation responses following administration of a brain-targeted 
drug [1]. PhMRI may be used as a non-invasive assay for neurotransmitter action, as 
has originally been shown for dopaminergic receptor stimulation [2, 3]. Another neu-
rotransmitter-specific network within the central nervous system, the cholinergic sys-
tem, modulates several cognitive functions such as attention, motor control, learning 
and memory. Functional imaging of the cholinergic system could potentially be useful 
in the diagnostic workup or evaluation of cognitive disorders. 
 The central cholinergic system consists of a diffuse neuronal network of projec-
tions from several basal forebrain nuclei towards the cerebral cortex and hippocam-
pus [4, 5]. The endogenous neurotransmitter at cholinergic synapses is acetylcholine. 
Its actions are mediated through nicotinic and muscarinic acetylcholine receptors 
(mAChRs), which transduce signals via distinct mechanisms. Whereas the functional 
response to nicotinic receptor stimulation with phMRI has recently been described [6-
8], the activation patterns upon muscarinic receptor stimulation have not been re-
ported previously. 
 The aim of this study was to investigate the spatial and temporal activation pat-
terns of the cholinergic system in rat brain with phMRI through stimulation of one of 
its major functional targets: the muscarinic acetylcholine receptor. 
MATERIALS AND METHODS 
Animals 
A total of thirty-one adult male Lewis rats were used, weighing 320-380 grams at the 
time of MRI experiments. All animal surgical and maintenance procedures were ap-
proved by the local ethical committee of Utrecht University and met governmental 
guidelines. All efforts were made to minimize animal suffering and limit the number of 
animals used. 
Experimental design 
Pharmacological MRI involved either blood oxygenation level-dependent (BOLD) MRI 
or contrast-enhanced cerebral blood volume (CBV)-weighted MRI combined with 
intravenous administration of the mAChR agonist pilocarpine. We chose this agent 
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because it readily crosses the blood-brain barrier and exerts its cerebral effect almost 
immediately [9], thereby anticipating a rapid and discriminative MR signal response. 
Because high dosage of pilocarpine is known to elicit seizure activity [10], we chose 
to use a low dose of 2.5 mg/kg that did not evoke epileptic-like behaviour in awake 
animals nor motion artifacts during MR experiments [data not shown]. Since pilo-
carpine induces profound  peripheral muscarinic effects (increased salivation, empty-
ing of bowel and bladder, and cardiorespiratory changes), all animals, except one 
group of drug-naïve rats (Group 2 (see below)), were subcutaneously pretreated with 
methylated scopolamine about 1 hour prior to the MR experiments. Methyl-
scopolamine is a mAChR antagonist that is unable to cross the blood-brain barrier, 
thereby blocking the peripheral muscarinic effects of pilocarpine. In pilot MRI experi-
ments, we found that intravenous administration of methyl-scopolamine did not evoke 
significant changes in BOLD and CBV-weighted signal in the brain [data not shown]. 
Preliminary dose-titration experiments using contrast-enhanced CBV-weighted MRI 
in methyl-scopolamine pretreated animals demonstrated absence of robust MR sig-
nal changes with pilocarpine dosages below 2.5 mg/kg (resp. 0.025 mg/kg, 0.25 
mg/kg, and 1.25 mg/kg) [data not shown]. 
 Experiments were performed in five groups of animals. First, BOLD MRI was 
conducted in combination with injection of i) vehicle solution of sterile saline in rats 
pretreated with methyl-scopolamine (Group 1; n=5); ii) pilocarpine in drug-naïve rats 
(Group 2; n=5); and iii) pilocarpine in methyl-scopolamine pretreated rats (Group 3; 
n=5). Second, contrast-enhanced CBV-weighted MRI was conducted in combination 
with injection of i) vehicle (Group 4; n=5); or ii) pilocarpine (Group 5, n=5) in methyl-
scopolamine pretreated rats. 
 The arterial blood pressure response to pilocarpine was recorded offline, either 
with (n=3) or without methyl-scopolamine pretreatment (n=3). The rats were anesthe-
tized with isoflurane, intubated endotracheally and mechanically ventilated with 3% 
isoflurane in O2/N2O (1/2). The right femoral artery was cannulated for continuous 
arterial pressure monitoring. A lateral tail vein was cannulated for intravenous ad-
ministration of pilocarpine. Upon injection, blood pressure was monitored for up to 60 
minutes. 
MRI experiments 
Rats were anesthetized with isoflurane and intubated endotracheally. A lateral tail 
vein was cannulated for the intravenous administration of either vehicle solution or 
2.5 mg/kg pilocarpine hydrochloride (Sigma-Aldrich, Zwijndrecht, The Netherlands); a 
second tail vein was cannulated in animals of Groups 4 and 5 for injection of contrast 
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agent. Approximately 60 minutes prior to phMRI, the animals received a subcutane-
ous injection of 1 mg/kg scopolamine methyl-bromide (Sigma-Aldrich, Zwijndrecht, 
The Netherlands). Animals were placed in a stereotaxic head frame and mechani-
cally ventilated with 3% isoflurane in O2/N2O (1/2). Body temperature was kept con-
stant at 36.5 – 37.5 °C using a feed-back regulated heating pad. Heart rate, blood 
oxygen saturation and expired CO2 levels were monitored continuously. Normocap-
nia was maintained by adjusting the ventilation frequency between 45 and 55 min−1 
and the maximum ventilation volume between 3 and 4 ml. Retrospectively, no signifi-
cant correlations were found between end-tidal CO2 and change in BOLD or CBV-
weighted signal. 
 T2-weighted MRI was performed at 4.7 T (SISCO/Varian systems, Palo Alto, CA, 
USA) using a spin-echo multi-slice sequence: repetition time (TR) = 3000 ms; echo 
time (TE) = 20 ms; data matrix = 128 x 128 points; field-of-view (FOV) = 35 x 35 
mm2; 16 x 1.2-mm slices. Repetitive BOLD MRI was performed using a gradient 
echo multi-slice sequence: TR = 500 ms; TE = 23 ms; pulse angle = 41°; data matrix 
= 64 x 64 points; FOV = 35 x 35 mm2; 16 x 1.2-mm slices; temporal resolution = 32 
s. During BOLD MRI, pilocarpine or vehicle was administered after 10 minutes of 
baseline measurements (20 scans); data acquisition continued for 30 minutes there-
after (60 scans). Contrast-enhanced CBV-weighted MRI was performed using a 
gradient-echo multi-slice sequence: TR = 520 ms; TE = 23 ms; pulse angle = 41°; 
data matrix = 64 x 64 points; FOV = 35 x 35 mm2; 20 x 1.0-mm slices; temporal 
resolution = 33 s. Following 10 pre-contrast scans, we intravenously injected ultra-
small superparamagnetic iron-oxide particles (Sinerem®, Guerbet, Aulnay-sous-Bois, 
France; 10 mg/kg). Contrast-enhanced CBV-weighted phMRI was started 15 minutes 
after injection of the contrast agent. After 10 minutes of baseline measurements (20 
scans), pilocarpine or vehicle was administered and data acquisition continued for 30 
minutes thereafter (60 scans). In each experiment, a total volume of 1 ml was in-
jected intravenously over a 60-second time period. The administration of pilocarpine 
or vehicle lasted 30 seconds and was followed by flushing with vehicle solution. 
Data processing and statistical analysis 
The phMRI response to pilocarpine was analyzed within several regions-of-interest 
(ROIs). To this end, BOLD and contrast-enhanced CBV-weighted MRI data of each 
experiment were coregistered to a reference Lewis rat brain using MNI AutoReg 
software [11]. Relative changes in CBV were calculated from the contrast-enhanced 
CBV-weighted MR data as described previously [12]. Based on the anatomical distri-
bution of mAChR in the rat brain [13], the following ROIs were defined: sensorimotor 
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cortex (24 voxels), striatum (24 voxels), rostromedial hippocampus (10 voxels) and 
thalamus (20 voxels). These ROIs were delineated bilaterally on the raw BOLD data 
or relative CBV data of each individual MR experiment. Post-injection signal re-
sponses were calculated as a percentage difference relative to mean baseline values 
within each ROI. 
 In addition, BOLD and contrast-enhanced CBV-weighted phMRI data were proc-
essed and analyzed within the framework of a general linear model (GLM) using 
SPM2 software package (http://www.fil.ion.ucl.ac.uk/spm). For each experiment, 
anatomical images were first spatially coregistered to a Lewis rat brain template that 
was created from twenty coronal T2-weighted anatomical images of a control rat. The 
transformation parameters were subsequently applied to the phMRI time-series data. 
To increase robustness for small differences in anatomical positioning and brain 
shape, data were smoothed using a Gaussian kernel with full-width-at-half-maximum 
of 1.1 mm (twice the in-plane resolution). 
 Group-level Independent Components Analysis (ICA) has been shown to be a 
useful method in extracting components of interest from fMRI data [14, 15]. The prin-
ciple advantage of this approach is its applicability to fMRI paradigms for which the 
MR-signal response is not known a priori. In this study, we used the Group ICA of 
fMRI Toolbox (GIFT) software package (http://icatb.sourceforge.net). The FastICA 
algorithm [16] was used to determine 20 independent components at group level. 
The following algorithm parameters were used (default): independent components = 
20; autofill data reduction = yes; epsilon = 0.0001; iteration = 1000; approach = defl; 
g = pow3. Within the experimental groups with pilocarpine administration, this ap-
proach produced one or two components showing specific and significant brain acti-
vation patterns. Selection of a particular component was based on the following crite-
ria: regional brain activation (sensitivity), no activation of extracranial areas (specific-
ity), and a smooth signal curve shape. Using these specific components as regres-
sors in SPM2, we performed a first level or model fitting analysis. Regressors were 
assessed in separate design matrices (one for each regressor). The autoregressive 
model of order 1, the AR(1) model, was used to calculate a true temporal correlation 
and to correct for serial correlations. No high-pass filter was applied due to the long 
pilocarpine activation time-frame. To make inferences about group data, a second 
level or random effect analysis was performed in SPM2 (one-sample t-test design, no 
grand mean scaling, global calculation omitted, statistical significance set at p<0.05, 
family-wise error corrected). 
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RESULTS 
Blood pressure 
Figure 1 shows the changes in mean arterial blood pressure (MABP) induced by 
pilocarpine. After pilocarpine injection into drug-naïve animals, MABP rapidly in-
creased to a maximum of 145 ± 5 mmHg (mean ± SD) in about 5 minutes and re-
turned to baseline levels within 20-30 minutes. Blocking of peripheral muscarinic 
receptors by methyl-scopolamine mitigated the elevation in blood pressure to a 
maximum of 93 ± 5 mmHg, which is within cerebral autoregulation levels. 
 
Figure 1. Mean arterial blood pressure responses (MABP, mean ± SD) following intravenous administration 
of pilocarpine in drug-naïve (closed circles) or methyl-scopolamine pretreated Lewis rats (open squares). 
Pretreatment with methyl-scopolamine mitigated the elevation of MABP to levels within cerebral autoregula-
tion. Note the similarity in baseline MABP between both groups. 
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BOLD MRI 
Figure 2 shows the time-courses of changes in BOLD signal in various ROIs. A 
BOLD signal increase upon injection of pilocarpine, starting within the temporal 
phMRI resolution of 30 seconds, was observed in all ROIs, most notably in the cere-
bral cortex. BOLD signal intensity increased to a maximum in about 1-3 minutes and 
normalized thereafter. Pilocarpine-induced peak changes in BOLD signal intensity 
were in the order of 4% in drug-naïve rats (Group 2) and in the order of 1-2% in 
methyl-scopolamine pretreated animals (Group 3). A significant BOLD response was 
absent following vehicle injection in methylscopolamine pretreated animals (Group 1). 
 
 
Figure 2. Time-courses of relative BOLD signal intensity changes (mean ± SEM) in various ROIs upon 
injection of vehicle in methyl-scopolamine pretreated rats (Group 1 (n=5)) (open circles), and pilocarpine 
in drug-naïve animals (Group 2 (n=5)) (closed squares) and methyl-scopolamine pretreated animals 
(Group 3 (n=5)) (crosses). 
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CBV-weighted MRI 
Prominent pilocarpine-induced activation responses in all ROIs were detected with 
contrast-enhanced CBV-weighted MRI (Group 5), as shown in Figure 3. Positive CBV 
changes developed rapidly in cortex, hippocampus and thalamus and were strongest 
in the cortex. Pilocarpine-induced peak CBV changes were in the order of 10-15%. A 
distinctive negative CBV response was detected in the striatum. In this ROI, CBV 
dropped by approximately 10% within 1 min and slowly recovered thereafter. No 
significant changes in CBV were observed in response to vehicle injection in control 
animals (Group 4). 
 
 
Figure 3. Time-courses of relative changes in CBV for the various ROIs (mean ± SEM) upon injection of 
vehicle (Group 4 (n=5)) (open circles) or pilocarpine (Group 5 (n=5)) (closed squares) in methyl-
scopolamine pretreated rats. 
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Statistical activation maps 
For the pilocarpine-treated Groups 2 and 3 in the BOLD MRI studies, ICA yielded 
single components that exhibited a profile that spatially and temporally corresponded 
to the selection criteria described in the ‘Materials and Methods’ section (see Figure 
4). For the contrast-enhanced CBV-weighted phMRI studies with pilocarpine admini-
stration (Group 5), two components showing opposite response profiles were found 
(see Figure 4). 
Figure 5 shows the activation maps that were calculated using the components de-
termined by ICA as regressors in SPM analysis. In drug-naïve (Group 2) and methyl-
scopolamine pretreated rats (Group 3), a significant positive BOLD response upon 
pilocarpine injection was primarily evident in the cerebral cortex. This was not ob-
served in methyl-scopolamine pretreated control animals that received vehicle solu-
tion (Group 1). With contrast-enhanced CBV-weighted MR imaging after pilocarpine 
injection (Group 5), significant responses in the cortex were associated with an MR 
signal decrease corresponding to an increase in CBV. In contrast, a significant in-
crease in MR signal (i.e., CBV decrease) was found in the striatum. No significant 
positive or negative responses were observed in control animals that received vehicle 
solution (Group 4). 
Figure 4. Regressors as determined by group-level independent components analysis (ICA) of phMRI data. 
Thin lines depict the regressors for pilocarpine-induced BOLD phMRI changes with (Group 3) (dashed line) 
and without peripheral muscarinic blockade (Group 2) (solid line). Thick solid and dashed lines depict the 
two regressors for pilocarpine-induced changes with contrast-enhanced CBV-weighted phMRI in methyl-
scopolamine pretreated rats (Group 5). 
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Figure 5. Statistical activation maps of pilocarpine-induced phMRI responses calculated from the regressors 
shown in Fig 4. First column: BOLD phMRI with vehicle injection (methyl-scopolamine pretreated) (Group 1). 
Second column: BOLD phMRI with pilocarpine injection (drug-naïve) (Group 2). Third column: BOLD phMRI 
with pilocarpine injection (methyl-scopolamine pretreated) (Group 3). Fourth column: CBV-weighted phMRI 
with vehicle injection (methyl-scopolamine pretreated) (Group 4), first regressor. Fifth column: CBV-weighted 
phMRI with pilocarpine injection (methyl-scopolamine pretreated) (Group 5), first regressor. Sixth column: 
CBV-weighted phMRI with pilocarpine injection (methyl-scopolamine pretreated) (Group 5), second regressor. 
Z-values are shown along a color spectrum from red (first to third column: z = 2; fourth column: z = -2) to 
yellow (first to third column: z = 10; fourth column: z = -10). 
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DISCUSSION 
The present study demonstrates that pharmacological MRI (phMRI) with the mus-
carinic acetylcholine receptor (mAChR) agonist pilocarpine allows in vivo assessment 
of mAChR stimulation in rat brain. Within 30 seconds up to 30 minutes after injection 
of pilocarpine, regional BOLD and CBV responses were detected in cerebral cortex, 
striatum, hippocampus and thalamus. Because the pattern of phMRI responses to 
pilocarpine is undetermined, we applied data-driven independent component analysis 
(ICA) to map the activation responses in the brain. Group-level ICA of fMRI data 
consistently yielded one or two components that met our selection criteria and effec-
tively corresponded with plausible pilocarpine-induced activation patterns. By using 
the GIFT-components as regressors in SPM analysis, statistical maps exhibited sig-
nificant activation in brain areas with known high mAChR density: cerebral cortex, 
striatum, hippocampus and thalamus [13]. The profile of these regressors corre-
sponded with the time-course of phMRI signal changes in our specified ROIs. 
 The muscarinic class of acetylcholine receptors are widely distributed throughout 
the body and subserve numerous vital functions in both the brain and autonomic 
nervous system. Five distinct mAChR subtypes have been identified, designated as 
M1 through M5 [17]. Both their absolute density and relative proportion decline to-
wards caudal regions of the brain. They are primarily expressed in the cerebral cortex 
(mostly M1), striatum (mostly M4), hippocampus and thalamus [13, 18]. Pilocarpine is 
a non-selective mAChR agonist. The significant BOLD and CBV-weighted MR signal 
responses we observed in the cerebral cortex are consistent with the notion that this 
brain region holds the highest density of mAChRs. Pilocarpine-induced phMRI re-
sponses in the brain may be explained either by blood flow increase upon neuronal 
activation of mAChR in the central nervous system or by direct hemodynamic effects 
caused by stimulation of peripheral mAChR on cortical microvasculature. Cortical 
microvessels are endowed with mAChRs [19] and stimulation of those receptors 
results in microvessel dilation and increased cortical perfusion [20-22]. 
 Our pilocarpine phMRI studies included two different functional MRI methods. 
First, we assessed the contribution of peripheral mAChR stimulation on phMRI-
detected responses in the brain using BOLD MRI. We compared pilocarpine-induced 
BOLD changes with and without subcutaneous pretreatment with methyl-
scopolamine, a peripheral mAChR antagonist that is unable to cross the blood-brain 
barrier, and does not evoke significant cerebral phMRI responses. The observed 
reduction in pilocarpine-induced phMRI responses following methyl-scopolamine 
pretreatment, indicates a substantial contribution of peripheral effects on phMRI-
based measurement of pilocarpine-induced brain activation. For the subsequent 
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study where we compared BOLD MRI versus contrast-enhanced CBV-weighted MRI, 
we therefore measured pilocarpine-induced activation after peripheral mAChR block-
ade. Activation responses in cerebral cortex, thalamus and hippocampus were more 
robustly detected with contrast-enhanced CBV-weighted MRI. Furthermore, a strong 
decrease in CBV was observed in the striatum; such a negative signal response was 
not observed with BOLD MRI. 
 The regionally specific brain signal changes are not likely to be primarily caused 
by the elevation of blood pressure upon pilocarpine administration. First, blocking of 
peripheral mAChRs with methyl-scopolamine mitigated the pilocarpine-induced in-
creases in blood pressure to within probable limits of cerebral autoregulation, which 
has been shown to be preserved in cortex and subcortex at the applied isoflurane 
anesthesia levels [23]. Second, the sole increase of MABP has been shown to have 
little effect on BOLD or CBV-weighted MRI signal in rat brain [24]. 
 Contrast-enhanced CBV-weighted phMRI showed robust pilocarpine-induced 
signal responses in cortical and subcortical regions. This corresponds with studies by 
Mandeville et al. [25], who have demonstrated enhanced sensitivity with the contrast-
enhanced CBV-based method compared to BOLD MRI, particularly for activation 
responses in subcortical structures. Interestingly, in contrast to the positive CBV 
response in the cerebral cortex, CBV decreased in the striatum following pilocarpine 
injection. An explanation for the lowering of CBV in the striatum might be the occur-
rence of a hemodynamic steal as a result of the strong increase in cortical perfusion. 
An alternative explanation may be related to the distribution of muscarinic receptor 
subtypes. As mentioned earlier, the M1 receptor subtype predominates in the cere-
bral cortex whereas the M4 subtype is found primarily in the corpus striatum. Func-
tionally, the odd-numbered mAChR (M1, M3, and M5) are thought to mediate excita-
tory synaptic transmission whereas the even-numbered receptors (M2 and M4) have 
been associated with inhibitory synaptic transmission [26]. Specifically, mAChR 
knock-out experiments in mice have shown that the M1 receptor modulates neuro-
transmitter signalling in the cortex whilst the M4 receptor acts as an inhibitory autore-
ceptor in the striatum [27]. Stimulation of M1 may thus produce a cortical response 
opposite to an M4-mediated striatal response. 
 In conclusion, our study shows that phMRI with pilocarpine induced significant 
activation responses in rat brain regions known to have a high density of muscarinic 
receptors, thereby demonstrating that activation of the cholinergic system can be 
assessed in vivo. This may provide a potential novel means for functional assess-
ment of the cholinergic system in humans. Ultimately, this approach could aid in the 
diagnosis of cognitive disorders such as Alzheimers’ disease and vascular cognitive 
impairment. 
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ABSTRACT 
Vascular cognitive impairment has been related to dysfunction of the central cho-
linergic system. Studies exploring the putative relationship between vascular cogni-
tive impairment and cholinergic dysfunction have largely been aimed at symptomatic 
cholinergic treatment rather than focusing on etiological and pathological factors. The 
present study characterizes subacute responses of the cholinergic system to focal 
cerebral infarction, investigating changes in muscarinic receptor activation and cho-
linergic cell number after photothrombotic infarction of the frontal cortex in rat brain. 
We conducted pharmacological magnetic resonance imaging (phMRI) to assess 
muscarinic receptor activation at 1 and 3 weeks after photothrombotic infarction in 
either the left of right frontal cortex. In addition, stereological assessment was per-
formed on choline acetyltransferase (ChAT)-immunostained sections to determine 
cholinergic cell body count and volume in several basal forebrain nuclei at 4 weeks 
after infarction. Reductions in muscarinic receptor activation were observed both 
inside the ischemic area at 1 and 3 weeks, and in areas distant from the lesion at 3 
weeks after right-sided frontal cortex infarction. We did not find changes in choliner-
gic cell number and volume. These results suggest that phMRI is a sensitive tool to 
detect alterations in cholinergic receptor function, without significant accompanying 
structural damage to the cholinergic system, following cerebral ischemia. Since the 
projecting cholinergic cells do not seem to degenerate after focal infarction, functional 
imaging of muscarinic receptor activation might be of interest for diagnosis and 
evaluation of therapy in vascular cognitive impairment. 
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INTRODUCTION 
Cognitive impairment related to cerebrovascular disease has received much attention 
in recent years with terminology such as vascular cognitive impairment or vascular 
dementia. Vascular cognitive impairment has been linked to cholinergic dysfunction, 
as cognitive performance is modulated by the brain’s cholinergic system [1-3]. Stud-
ies exploring the putative relationship between vascular cognitive impairment and 
cholinergic dysfunction have largely been aimed at symptomatic cholinergic treat-
ment rather than focusing on etiological and pathological factors [4]. 
 The central cholinergic system projects from several basal forebrain nuclei pri-
marily towards the cerebral cortex and hippocampus, both in humans and in lower 
vertebrates like the rat [5, 6]. Recently, we have shown that several cognitive impair-
ments seen in human stroke patients can be modelled in rats by measuring reaction 
time responding and attention performance after cortical infarction [7, 8]. Experimen-
tal studies on the degeneration of the basal forebrain cholinergic system in the adult 
rat have focused on two components of this system: a) the basalo-cortical pathway, 
from the basal nucleus towards the neocortex, and b) the septo-hippocampal path-
way, from the medial septal nucleus towards the hippocampus. The rat cerebral 
cortex receives its cholinergic input mainly from neurons of the basal nucleus. The 
cholinergic basalo-cortical pathway does not follow a well-defined route like the 
septo-hippocampal pathway, but radiates out medially and laterally from the basal 
forebrain. Damage to these two pathways causes anterograde and retrograde axonal 
degeneration within the first four weeks [Henderson, 1996], which may result in cell 
death of cholinergic neurons. It has been reported that secondary cell death does not 
occur in the basal nucleus after cortical lesioning, supposedly because the cells of 
the basalo-cortical pathway have more widespread projections [9]. 
 The endogenous neurotransmitter at cholinergic synapses is acetylcholine, which 
actions are mediated through nicotinic and muscarinic acetylcholine receptors. Previ-
ously, we have demonstrated the feasibility of pharmacological functional magnetic 
resonance imaging (phMRI) for functional assessment of muscarinic receptor activa-
tion in rats in vivo. PhMRI is a variant of functional MRI that allows measurement of 
cerebral activation responses following administration of a brain-targeted drug [10]. 
Immunohistochemistry and autoradiography studies have reported reduced numbers 
of muscarinic receptors and muscarinic receptor binding in the ipsilateral hemisphere 
after ischemia to the frontoparietal cortex, presumably through the degeneration of 
the basalo-cortical pathway [11-15]. 
In the present study, we investigated structural and functional alterations of the cho-
linergic system after focal infarction of the frontal cortex in rats. We hypothesized that 
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cortical ischemia would result in reduced cortical muscarinic receptor activation and a 
reduced number of cortically projecting cholinergic cells. Therefore we characterized 
subacute changes in the cholinergic system after cortical infarction by measurement 
of muscarinic receptor activation and cholinergic cell number both in- and outside the 
infarcted area. 
MATERIALS AND METHODS 
Animals 
Animal surgical and maintenance procedures were approved by the local ethical 
committees of Maastricht University (Maastricht, The Netherlands) and Utrecht Uni-
versity (Utrecht, The Netherlands) and met Dutch governmental guidelines. All ex-
periments were conducted with adult male Lewis rats weighing 280-320 g at the start 
of the experiments. We performed two types of experiments. In one experiment, 
phMRI of cerebral muscarinic receptor activation was conducted in sham-operated 
rats and in animals after unilateral photothrombotic infarction to either the right or left 
frontal cortex (Experiment I). In another experiment, we determined cholinergic cell 
number in several basal forebrain nuclei following sham-operation or after unilateral 
photothrombotic infarction to the right or left frontal cortex (Experiment II). 
Photothrombotic cortical infarction 
Body weight was matched between experimental groups prior to the induction of 
photothrombotic cortical infarction or sham operation. Anaesthesia was induced by 
inhalation of isoflurane (4%) and maintained with isoflurane (1%) in a mixture of 
O2/N2O (1:2) in spontaneously breathing rats. As described previously [16], cortical 
infarction was induced by photochemically initiated thrombosis through intravenous 
injection of the light-sensitive dye Erythrosin B (Sigma-Aldrich, Zwijndrecht, The 
Netherlands) and illumination of the skull with a monochromatic light source (DPSS 
laser, Uniphase, Germany). The light source, with a diameter of 2.4 mm, was posi-
tioned perpendicular to the skull surface in the centre of a perforated filtration paper 
that absorbed any leakage of blood. Its beam was positioned at 2.7 mm anterior and 
2.7 mm lateral to bregma’s point for infarction of the frontal cortex. In sham-operated 
animals, the order of dye injection and illumination was reversed. 
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Experiment I – phMRI of muscarinic receptor activation 
Assessment of muscarinic receptor activation using phMRI was performed in five 
groups of animals: sham-operated (n=5), at 1 and 3 weeks after left frontal cortex 
infarction (n=5 for each time-point), and at 1 and 3 weeks after right frontal cortex 
infarction (n=5 for each time-point). Since the administration of the pharmacological 
agent and the contrast agent are possible confounding factors in repetitive MRI ex-
periments, phMRI was performed as a single-event and not repeated over time in the 
same animal. 
phMRI 
Pharmacological MRI combined contrast-enhanced cerebral blood volume (CBV)-
weighted MRI with intravenous administration of the muscarinic acetylcholine recep-
tor agonist pilocarpine (see chapter 5). In short, rats were anesthetized with isoflu-
rane and intubated endotracheally. A lateral tail vein was cannulated for injection of 
contrast agent. A second tail vein was cannulated for the administration of 2.5 mg/kg 
pilocarpine hydrochloride (Sigma-Aldrich, Zwijndrecht, The Netherlands). Animals 
were placed in a stereotaxic head frame and mechanically ventilated with 3% isoflu-
rane in O2/N2O (1/2). Body temperature was kept at 36.5 – 37.5 °C using a feed-
back regulated heating pad. Heart rate, blood oxygen saturation and expired CO2 
levels were monitored continuously. Approximately 60 minutes prior to phMRI, we 
subcutaneously injected 1 mg/kg scopolamine methyl-bromide (Sigma-Aldrich, 
Zwijndrecht, The Netherlands), to block peripheral muscarinic effects of pilocarpine 
(see Chapter 5). 
 T2-weighted MRI was performed at 4.7 T (SISCO/Varian systems, Palo Alto, CA, 
USA) using a spin-echo multi-slice sequence: repetition time (TR) = 3000 ms; echo 
time (TE) = 20 ms; data matrix = 128 x 128 points; field-of-view (FOV) = 35 x 35 
mm2; 16 x 1.2-mm slices. Contrast-enhanced CBV-weighted MRI was performed 
using a gradient-echo multi-slice sequence: TR = 520 ms; TE = 23 ms; pulse angle = 
41°; data matrix = 64 x 64 points; FOV = 35 x 35 mm2; 20 x 1.0-mm slices; temporal 
resolution = 33 s. Following 10 pre-contrast scans, we intravenously injected ultra-
small super paramagnetic iron-oxide particles (Sinerem®, Guerbet, Aulnay-sous-
Bois, France; 10 mg/kg). The blood half-life of Sinerem® in Lewis rats at this dose is 
about 5-6 hours [17]. Contrast-enhanced CBV-weighted phMRI was started 15 min-
utes after injection of contrast agent. Pilocarpine was administered after 10 minutes 
of baseline measurements (20 scans), and data acquisition continued for 30 minutes 
thereafter (60 scans). 
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Data processing and statistical analysis 
The phMRI response to pilocarpine was analyzed within several regions-of-interest 
(ROIs). To this end, contrast-enhanced CBV-weighted MRI data of each experiment 
were coregistered to a rat brain MRI template. Relative changes in CBV were calcu-
lated from the contrast-enhanced CBV-weighted MRI data as described previously 
[18]. Using Paxinos and Watson’s rat brain atlas in stereotaxic coordinates [19], the 
following ROIs were delineated bilaterally on the relative CBV maps of each individ-
ual: motor cortex (M2), sensory cortex (S2), and striatum (CPu) [see Figure 1]. 
 
Figure 1. Coronal rat brain sections showing ROIs for the analysis of number of ChAT-immunopositive 
neurons (left images) and muscarinic receptor activation (right images). Upper left image shows medial 
septum (Ch1) and horizontal/vertical limb of diagonal band of Broca (Ch2/3); note the artificial line connect-
ing the upper parts of anterior commissure that was used to make a reliably distinction between these two 
ROIs. Lower left image shows the basal nucleus ROI (Ch4). Right images show ROIs in motor cortex (M2) 
and sensory cortex (S2) and striatum (CPu). 
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Since the photothrombotic lesions were located in the rostral frontal cortex, the ROI 
of the motor cortices were subdivided into areas located inside versus outside of the 
ischemic lesion (3.24 to 2.28 mm versus 1.08 to -1.08 mm anterior/posterior to 
bregma, respectively). The sensory cortex was delineated from 1.08 to -1.08 mm 
anterior/posterior to bregma, and the striatum from 2.04 to 1.08 mm anterior/posterior 
to bregma. Signal responses within each ROI were calculated separately for the left 
and right hemisphere, as well as combined for both hemispheres. All statistical 
analyses were done using SPSS software (version 12). The CBV changes over time 
were analysed in a repeated measures within-subjects ANOVA design using general 
linear modelling (GLM). Within-subject factor was phMRI time-point after pilocarpine 
injection (Time - 120 levels) and between-subjects factor was experimental group 
(Group – 5 levels), followed by a post-hoc LSD correction for multiple comparisons. 
Data output was split into results by ROI and results by hemisphere (both, left or 
right). 
 Additionally, contrast-enhanced CBV-weighted phMRI data were processed and 
analyzed within the framework of FMRIB's Software Library (FSL, 
www.fmrib.ox.ac.uk/fsl). The contrast-enhanced CBV-weighted phMRI time-series 
were motion corrected with the FMRIB's Linear Image Registration Tool (MCFLIRT; 
[20, 21]). To increase robustness for small differences in anatomical positioning and 
brain shape, data were spatially smoothed using a Gaussian kernel with full-width-at-
half-maximum of 1.0 mm (twice the in-plane resolution) followed by grand-mean 
intensity normalization of the 4D datasets by a single multiplicative factor. Two main 
explanatory variables from the sham group were selected from a group-level data 
analysis using probabilistic independent component analysis as implemented in ME-
LODIC (Multivariate Exploratory Linear Decomposition into Independent Compo-
nents), part of FSL. The melodic input data were pre-processed as followed: masking 
of non-brain voxels; voxel-wise de-meaning and normalization of the voxel-wise vari-
ance. Pre-processed data were whitened and projected into a multi-dimensional 
subspace using probabilistic principal component analysis where the number of di-
mensions was estimated using the Laplace approximation to the Bayesian evidence 
of the model order [22]. The whitened observations were decomposed into sets of 
vectors which describe signal variation across the temporal domain (time-courses), 
the subject domain and the spatial domain (maps) by optimizing for non-Gaussian 
spatial source distributions using a fixed-point iteration technique [23]. Estimated 
component maps were divided by the standard deviation of the residual noise and 
thresholded by fitting a mixture model to the histogram of intensity values [22]. The 
two selected explanatory variables (for positive and negative pilocarpine-induced 
CBV-responses, respectively) had explained variance of 11.73% and 5.37% respec-
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tively and were smoothed with a 3-th order b-spline function in the Curve Fitting 
Toolbox (version 1.1.7; Matlab, The MathWorks) prior to inclusion in the design ma-
trix. The model-based phMRI analysis was carried out using FMRI Expert Analysis 
Tool version 5.91, part of FSL. The analysis contained local autocorrelation correc-
tion and first-level GLM time-series analysis. First-level contrast images were subse-
quently used for high-level analysis with one-sample t-test setup to measure the 
mean group effect (i.e., to establish whether the group activates on average). For 
higher-level activation estimation we applied FMRIB's Local Analysis of Mixed Effects 
(FLAME). FLAME uses Bayesian modelling and estimation. The Z (Gaussianized 
T/F) statistic image was thresholded using clusters determined by Z>2.3 and a (cor-
rected) cluster significance threshold of p=0.05 [24]; Worsley 2001). Finally, Z statis-
tic parametric group maps were overlaid on the structural MRI template used for 
coregistration. 
Experiment II – Immunohistochemistry of cholinergic cells 
Fifteen animals were randomly selected from the experimental groups described in a 
previous behavioural study [7]: sham-operated animals (n=5), left frontal cortex in-
farction (n=5), and right frontal cortex infarction (n=5). Age and body weight did not 
differ between groups. Lesion volume histology and choline acetyltransferase (ChAT) 
immunohistochemistry were performed at 4 weeks after infarction or sham-operation. 
Tissue preparation 
Rats were anaesthetized with sodium pentobarbital (Nembutal®, 60 mg/kg i.p.). Sub-
sequently, perfusion fixation was performed by transcardial administration of ice-cold 
0.1 M tyrode buffer (pH 7.6) followed by Somogyi’s fixative (pH 7.4) consisting of 4% 
paraformaldehyde, 15% picric acid and 0.05% glutardyaldehyde in 0.1 M phosphate 
buffer at 70 mmHg. Brains were removed from the cranium, and immersion-fixed for 
another 2 hours in Somogyi’s fixative. Overnight, brain tissue was cryoprotected by 
immersion in 15% sucrose / 0.1 M phosphate buffer at 4 ˚C. Afterwards, the brains 
were quickly frozen on CO2 gas and stored at -80 ˚C until further processing. Brains 
were cut on a cryostate (Leica CM 3050, Nussloch, Germany) into 30 μm coronal 
sections collected serially. For the quantification of lesion volume every fifth section 
was stained on slides with a May-Grunwald-Giemsa protocol [25], and calculated as 
described previously [7]. 
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ChAT immunohistochemistry 
For the quantification of cholinergic cells every fourth 30 μm free-floating coronal 
section was stained immunohistochemically for ChAT. In brief, the sections were 
rinsed three times in Tris-buffered saline (TBS, 0.01 M) with 0.2% Triton X-100 (TBS-
T) followed by incubation for 72 hours at 4˚C with the primary antibody (rat anti-
ChAT, Eckenstein, 1:800) in TBS-T and 3% donkey serum. After another three rinses 
in TBS-T, the sections were incubated overnight at 4˚C with a secondary antibody 
(biotinylated donkey anti-rat, 1:400) in TBS-T and 3% donkey serum. Staining was 
visualized at room temperature for 10 minutes using the ABC method with a vec-
tastain kit (Vector Laboratories, Burlingame, CA), 0.3% 3’3’-diaminobenzidine (DAB, 
Sigma), 0.3 % nickelchloride and 0.3% hydrogenperoxide in TBS-T. Counterstaining 
was carried out with cresyl violet. Sections were washed with TBS, mounted onto 
gelatinized glass slides, dehydrated, cleared, and coverslipped using DePeX. 
Cell counting and volume estimation 
ChAT-immunopositive neurons were quantified using a stereology work station con-
sisting of a modified light microscope (Olympus BX50; Olympus, Tokyo, Japan), 
Olympus UPlanApo objectives (10x, NA = 0.40; 100x, oil, NA = 1.35), a motorized 
specimen stage for automatic sampling (Maerzhauser, Wetzlar, Germany), an elec-
tronic microcator (Heidenhain, Traunreut, Germany), a CCD color video camera (JAI, 
Glostrup, Denmark), a PC with framegrabber board (Screen Machine II, Fast Multi-
media, Munich, Germany), stereology software (C.A.S.T.-Grid, Olympus; StereoIn-
vestigator, MicroBrightField, Inc., Colchester, VT) and a 17-inch television screen 
monitor. 
 All ChAT-immunopositive cell bodies were counted in the following ROIs accord-
ing to Mesulam [26]: medial septum (Ch1), horizontal and vertical limbs of the diago-
nal band of Broca (Ch2 and Ch3), and basal nucleus and substantia innominata 
(Ch4) [see Figure 1]. These ROI were delineated in both cerebral hemispheres at x10 
magnification on whole-brain sections using The Atlas of the Rat Nervous system 
[19]. For reliable measurements and adequate number of ChAT-positive cells per 
ROI, we delineated areas Ch1 and Ch2/3 between 1.20 mm (anterior boundary) and 
0.24 mm (posterior boundary) from bregma. When the distinction between these two 
areas could not be made reliably, we used an artificial division by drawing a straight 
line connecting the upper parts of anterior commissure. Area Ch4 was delineated 
between -1.56 mm (anterior boundary) and -2.64 mm (posterior boundary) from 
bregma, as the alignment of cholinergic cells of the basal nucleus between the exter-
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nal globus pallidus, internal capsule and optic tract. The remainder of cholinergic 
cells within the horizontal limb of the diagonal band of Broca, the substantia innomi-
nata and the basal nucleus were excluded because of either difficulties in reliable 
delineation or insufficient number of ChAT-positive cell bodies per tissue section. To 
correct for possible differences in ROI size between hemispheres, the total area of 
each ROI was calculated for every animal. 
 Total numbers of ChAT-positive neurons were evaluated with the fractionator at 
100x magnification. All neurons which nucleus or soma with axon hillock came into 
focus within the unbiased virtual counting frames distributed systematically over the 
entire delineated ROI were counted. Eight serial sections of each rat brain were used 
to calculate the total number of cholinergic cells within each ROI. Countings were 
performed in duplicate by two persons blinded for the experimental group. In addi-
tion, the optical fractionator was used in a subset of animals to estimate cell body 
volume (n=2 per group). 
 Analyses were performed using SPSS (v.12). For each experimental group, 
mean and standard errors of the mean were calculated for the total number of ChAT-
positive neurons and their estimated volume. Comparisons between groups were 
performed with a Student’s two-tailed t-test. Statistical significance was set at p<0.05. 
Statistical analysis 
Analyses were performed using SPSS (version 12). For each experimental group, 
mean and standard errors of the mean were calculated for the total number of ChAT-
positive neurons and their estimated volume. Comparisons between groups were 
performed with a Student’s two-tailed t-test. Statistical significance was set at p<0.05. 
Results 
Experiment I – phMRI of muscarinic receptor activation 
Figure 2 shows T2-weighted MR images of rat brain at 1 week and at 3 weeks after 
photothrombotic infarction in the frontal cortex. The lesion is characterized as a hy-
perintense region. One of the 25 animals died during the induction of photothrom-
botic infarction. Final group number for statistical analysis was: sham-operated ani-
mals (n=5), left frontal cortex infarction at 1 week (n=4), left frontal cortex infarction at 
3 weeks (n=5), and right frontal cortex infarction at 1 and 3 weeks (n=5 in each 
group). All of the statistical analyses described compare ROI data of the ipsilesional 
hemisphere after photothrombotic infarction versus after sham operation. 
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Figure 3 depicts relative CBV time-courses in different groups and ROIs in response 
to muscarinic receptor stimulation with pilocarpine. Figure 3, first row, shows a reduc-
tion in CBV response inside the infarcted area of the motor cortex after photothrom-
botic stroke to the frontal cortex (Time: F(79,1501)=1.55, p<0.01; Time*Group: 
F(316,1501)=1.85, p<0.001). Post-hoc analysis did not show this to be significant for 
right-sided lesioned animals at 1 week and 3 weeks (p=0.065 and p=0.055, respec-
tively) as well as for left-sided lesioned animals (p=0.269 and p=0.169, respectively). 
 Figure 3, second row, shows the time-courses of pilocarpine-induced CBV 
changes in the sensory cortex distant from photothrombotic infarction to either the left 
or right frontal cortex (Time: F(79, 1501)=17.26, p<0.001; Time*Group: 
F(316,1501)=3.0, p<0.001). CBV changes were not significantly reduced at 1 week 
post-infarction in the left-hemisphere lesion group (p=0.130) whereas in the right-
hemisphere lesion group CBV changes were notably reduced at 3 weeks (p<0.05). 
 Figure 3, third row, shows the time-courses of pilocarpine-induced CBV changes 
in the ipsilesional striatum after photothrombotic infarction to either the left or right 
frontal cortex (Time: F(79,1501)=6.71, p<0.001; Time*Group: F(316, 1501)=3.01, 
p<0.001). Compared to sham-operated animals, a significantly stronger negative 
CBV response was found in the right-hemisphere lesion group at 3 weeks post-
infarction (p<0.01). 
Figure 2. T2-weighted MR images showing right-sided infarction of 
the cortex in rat brain after 1 week (left) and 3 weeks (right) of
photothrombotic infarction. 
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Figure 3. Time-courses of muscarinic receptor stimulation induced CBV changes using pilocarpine. 
Graphs show CBV responses in various ROIs after sham operation (sham), and at 1 week and 3 weeks 
after left-sided cortical infarction (left column: L7 and L21, respectively) and right-sided cortical infarction 
(right column: R7 and R21, respectively). ROI data were extracted from the ipsilesional hemisphere and  
r bars represent standard error of the mean. compared to the ipsilateral side in sham-operated animals. Erro
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Figure 4. Regressors derived from FSL analyses: positive and negative signal components 
 
 
Figure 4 depicts the regressors as derived from pharmacological MRI data analysis in 
FSL. Figure 5 shows the activation maps that were calculated using these regressors 
in the control group of sham-operated animals. Positive CBV responses were noted 
in the posterolateral cerebral cortex whereas negative activation responses were 
found mainly in the striatum. 
 
 
 
Figure 5. Statistical activation maps calculated using the regressors derived from FSL analyses. In sham-
operated animals, positive pilocarpine-induced CBV changes were found in the cortex (on left) whereas 
negative pilocarpine-induced CBV changes were found in the striatum (on right). 
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Figures 6a and 6b show the calculated activation maps based on applying the FSL 
regressors for the various experimental groups. Compared to sham operation, posi-
tive activation responses were more pronounced after left-hemisphere infarction and 
at 1 week after right-hemisphere infarction, particularly in the lateral cortex, ros-
tromedial hippocampus and thalamus (Figure 6a). At 3 weeks after right-hemipshere 
infarction, positive activation responses were markedly reduced in the cortex. A simi-
lar picture was observed for the negative activation in the striatum (Figure 6b), where 
negative activation responses were found to be more pronounced after right-
hemisphere infarction and at 1 week after left-hemisphere infarction, particularly in 
the rostromedial cortex, hippocampus and thalamus. Negative activation responses 
in the striatum were diminished as compared to sham-operation, most notably at 3 
weeks after left-hemisphere infarction. 
 
 
Figure 6a. Statistical activation maps using the regressor for positive pilocarpine-induced CBV response at 1 
week and 3 weeks after left hemisphere infarction (top row) and after right hemisphere infarction (bottom 
row). 
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Figure 6b. Statistical activation maps using the regressor for negative pilocarpine-induced CBV response at 1 
week and 3 weeks after left hemisphere infarction (topr row) and after right hemisphere infarction (bottom 
row). 
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Experiment II – Immunohistochemistry of cholinergic cells 
We refer to our previous publication for histological features of unilateral frontal cor-
tex infarction [7]. Lesion volume did not differ between left-hemisphere and right-
hemisphere lesion groups (respectively, 1.27 ± 0.18 mm3 vs. 1.45 ± 0.45 mm3; 
p=0.72, ns); none of the sham-operated animals had a lesion. 
 Table 1, left, shows the total number of cholinergic cells in the various ROIs. No 
significant differences were found between the lesion groups versus sham-operation 
for cholinergic cell number in the medial septum (Ch1), diagonal band (Ch2/3) or 
basal nucleus (Ch4), neither in the ipsilesional nor the contralesional hemispheres. 
The volume of the ROIs did not differ between hemispheres or between experimental 
groups. 
 Table 1, right, shows the estimated volume of cholinergic cell bodies in the vari-
ous ROIs. No significant differences were found between the lesion groups versus 
sham-operation for cell body volume in areas Ch1-4, neither in the ipsilesional nor 
the contralesional hemispheres. 
 
Table 1. Total cell number and estimated cell volume of cholinergic cells in the various regions-of-interest: 
medial septum (Ch1), diagonal band (Ch2/3) and basal nucleus (Ch4). 
 sham right frontal left frontal 
Total cell number    
right 420 ± 33 439 ± 22 464 ± 19 Ch1 
left 401 ± 48 444 ± 22 463 ± 13 
right 649 ± 85 587 ± 40 742 ± 30 Ch2/3 
left 681 ± 95 605 ± 59 842 ± 68 
right 612 ± 29 614 ± 25 645 ± 21 Ch4 
left 582 ± 55 659 ± 69 599 ± 30 
Estimated cell volume 
right 1037 ± 55 1102 ± 129 889 ± 58 Ch1 
left 989 ± 81 1113 ± 123 893 ± 76 
right 1255 ± 89 1496 ± 192 1420 ± 71 Ch2/3 
left 1359 ± 46 1277 ± 99 1455 ± 31 
right 1750 ± 60 1708 ± 157 1868 ± 61 Ch4 
left 1703 ± 59 1691 ± 97 1829 ± 55 
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DISCUSSION 
Human vascular cognitive impairment has been related to dysfunction of the central 
cholinergic system. The present experiments investigated responses of the choliner-
gic system to focal cerebral infarction in rat brain by examining muscarinic receptor 
activation and cholinergic cell number after photothrombotic infarction to the frontal 
cortex. 
 First, we performed single-event phMRI to assess cerebral muscarinic receptor 
activation at 1 and 3 weeks after photothrombotic infarction of either the left or right 
frontal cortex. These time-points were chosen on the basis of previously conducted 
behavioural studies that produced differential effects in cognitive performance [7, 8]. 
ROI analysis of the relative CBV changes in the ipsilesional hemisphere showed 
reductions in muscarinic receptor activation inside the ischemic area at 1 and 3 
weeks after right-sided cortical infarction, although these reductions were not statisti-
cally significant. Significant activation changes were detected at 3 weeks after right-
hemisphere infarction in the sensory cortex as well as striatum distant from the 
ischemic lesion. In contrast, statistical activation maps calculated in FSL showed 
more pronounced cortical activation in all lesion groups except for right-hemisphere 
infarction at 3 weeks. Furthermore, the statistical maps showed a negative activation 
response in the cortex at 1 week in both lesion groups and at 3 weeks after right-
sided infarction. 
 The apparent mismatch between the results of ROI analysis versus FSL analysis 
can be explained as follows: 1) ROI analysis compares mean MR signal changes 
between experimental groups whereas FSL analysis is based on a statistical fitting of 
two probabilistic signal components deduced from sham-operated animals to the 
various lesion groups; 2) the cortical areas with reduced mAChR activation in the ROI 
analysis are different from the areas showing increased cortical activation in the FSL 
analysis. We lack a sound explanation for the observation that the two probabilistic 
components chosen from FSL analysis (cortex and striatum) showed several other 
positive and negative activation responses as compared to sham operated animals in 
areas such as hippocampus and thalamus. 
 Our phMRI findings corroborate previous ex vivo observations using immunohis-
trochemistry and autoradiography that have shown alterations in muscarinic acetyl-
choline receptor (mAChR) number and mAChR binding after brain ischemia in rats. 
Using different models of global and focal subcortical ischemia, Mizobuchi et al. [15] 
found decreased numbers of mAChR and increased mAChR binding affinity inside 
ischemic areas, whilst subsequent reperfusion caused the number of mAChR to 
increase. These mAChR changes occurred within hours after induction of ischemia, 
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whereas significant decreases in cholinergic cell number in the hippocampus were 
only found after a few days. Barbelivien et al. observed reduced muscarinic subtype 
M1 receptor density in the ipsilateral cortex and basal nucleus following an ischemic 
insult to the frontoparietal cortex by permanent distal middle cerebral artery occlusion 
(MCAO) [11]. Alterations in mAChR binding have also been shown after transient 
forebrain ischemia [12]. Nagasawa et al. [14] have shown decreased mAChR binding 
in the ipsilateral cerebral cortex and lateral segment of the caudate putamen after 
transient MCAO followed by 3 days of recirculation. Moreover, several days after 
ischemia significant decreases were observed in areas that had not been directly 
affected by the original ischemic insult. Interestingly, an asymmetry in mAChR bind-
ing sites and distribution of mAChR subtypes has been described, in which the right 
cerebral cortex shows higher receptor densities compared to the left [27]. In addition, 
it was shown that the down-regulation process of muscarinic receptors is more active 
in the right than in the left cerebral cortex of the rat. This may explain why in our 
study reduced muscarinic receptor activation was found particularly after right-
hemisphere infarction. 
 Second, we determined the number and volume of ChAT-immunopositive cells in 
several basal forebrain nuclei. We did not find a significant alteration in cholinergic 
cell number or cell body volume following focal infarction to the right or left frontal 
cortex. Concerning putative retrograde changes in basal forebrain neurons of the 
cerebral cholinergic system, our study corroborates previous findings in rats, in which 
secondary cell death was not observed in the basal nucleus after lesioning its target 
area, the cerebral cortex [9, 28]. Unilateral cortical damage has instead been shown 
to cause cellular swelling followed by permanent shrinkage of basal nucleus cho-
linergic neurons ipsilateral to the lesion [9, 29-31]. Subcortical ischemia induced by 
transient MCAO, however, has been reported to cause delayed neuronal degenera-
tion in ischemic foci as well as remote areas [14]. Since large portions of the cho-
linergic system were lesioned in these studies, our localized photothrombotic cortical 
lesion may have been too small to induce significant alterations in basal forebrain cell 
structure. 
 In contrast to the absence of structural degeneration of cholinergic cells in the 
basal forebrain, our phMRI results demonstrate considerable functional changes 
within the cholinergic system. Several lines of evidence have indicated that the cen-
tral cholinergic system is sensitive to ischemia, and even mild hypoxia may impair the 
synthesis of acetylcholine (for review see: [32]). Cholinergic receptors are particularly 
involved in the control of cerebral blood flow, by mediating vasodilatation of cortical 
microvessels upon stimulation of cholinergic cells in the basal forebrain. The impor-
tance of these receptors is underscored by our observations showing widespread 
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changes in cortical activation, both inside and distant from an ischemic territory. Vas-
cular cognitive impairment may therefore be partly related to an ischemia-induced 
breakdown in cholinergic neurogenic control of cerebral blood flow [33]. In humans, 
functional neuroimaging has recently been applied to measure changes in regional 
brain activation during cognitive task performance after pharmacologic manipulation. 
In patients with Alzheimer’s disease and mild cognitive impairment, recent reports 
have demonstrated alterations in brain activation after acute and prolonged admini-
stration of acetylcholinesterase inhibitors [34-39]. Comparable studies with respect to 
human vascular cognitive impairment, however, are lacking. 
 In conclusion, we have shown changes in muscarinic receptor activation without 
degeneration of cholinergic cells after a relatively small infarction of the cerebral 
cortex in rat brain. Functional imaging of muscarinic receptor activation may therefore 
be an interesting tool for future studies on the diagnosis and therapeutic evaluation of 
vascular cognitive impairment. 
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Vascular pathology is increasingly recognized as a common cause of cognitive im-
pairment in the elderly. Vascular cognitive impairment (VCI) is a heterogeneous 
group of cognitive disorders that share a presumed vascular cause. It is associated 
with large vessel disease, with small vessel disease including subcortical ischemic 
vascular disease, and with non-infarct ischemic changes [1]. VCI can potentially be 
prevented or the course of cognitive decline ameliorated. One of the suggested 
treatment options has been modulation of the central cholinergic system [2], which is 
known to play a major role in cognitive performance. The present thesis explored the 
putative relationship between the development of VCI and damage to the central 
cholinergic system in an animal model of cerebral infarction. To this end, cortical 
infarction was produced in rat brain by application of the photothrombotic stroke 
model that allowed for the investigation of: (1) cognitive effects without confounding 
by gross sensorimotor deficits and (2) local as well as remote changes to the cho-
linergic system. 
Vascular cognitive impairment: behavioural analysis in rat brain 
In the first part of this thesis, the objective was to establish an experimental equiva-
lent of human VCI. Rodents are the most commonly employed animals to model 
human cognitive function. Much of the scepticism towards rat models arises from the 
expectation that neurological symptoms should have the same manifestation across 
species [3]. The modelling of human-like symptoms in animals should however be 
made primarily on the basis of an expectation of functional similarity, rather than on 
one of physical identity. The use of such a comparative approach allows the assess-
ment of cognitive processes in rats which appear to be activated in humans when 
performing cognitive tasks. Advances have been made in identifying rat equivalents 
of neurological deficits seen in human diseases such as Parkinson’s disease, trau-
matic brain injury and ischemic stroke. Both stroke and traumatic brain injury can 
produce focal and widespread secondary damage in the brain, which can yield acute 
and chronic impairments of sensory, motor and cognitive functions. The focus on 
neuroprotection and recovery of motor function in clinical stroke research has been 
replaced over the last decade by a view incorporating VCI. In parallel, the importance 
of behavioural outcome measures in addition to histological assessment has become 
increasingly recognized in experimental stroke research [4]. Commonly used histo-
logical techniques, such as counts of residual neurons or determinations of infarct 
lesion volume, cannot detect subtle cellular alterations that might cause neuronal 
dysfunction. Accordingly, there is ample evidence of dissociation between behav-
ioural and histological endpoints in animal models of stroke [5]. 
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The interpretation of complex cognitive data in experimental stroke research can be 
problematic because stroke is often associated with sensorimotor deficits that may 
become confounding factors. In our studies such a confounder is not likely. The pho-
tothrombotic model produces relatively small cortical lesions. In the reaction time 
experiments these lesions were located outside of the sensorimotor cortex, and nor-
mal behaviour including gross motor function was already observed within hours of 
photothrombotic infarction. Moreover, motor response latency was measured in the 
order of milliseconds and did not increase upon infarction suggesting that the execu-
tion of movement was unaffected. 
 The pattern of cognitive deficits in patients with VCI varies considerably. Patients 
who have had a stroke, however, are most frequently affected by global impairments 
in attention and cognition. These general impairments are more closely associated 
with worse functional outcomes than executive dysfunction and isolated memory 
deficits. Single strategic infarcts can lead to specific cognitive profiles, whereas sub-
cortical lesions are often associated with abnormalities of information processing 
speed, executive function, and emotional liability. This cluster of features, termed the 
subcortical syndrome, can also present with deficits that result from cortical lesions. 
In accordance with these considerations, the present thesis shows that cortical infarc-
tion in rat brain produces two common types of post-stroke cognitive deficits (slowing 
of information processing speed, impairment of attention performance) observed in 
the subcortical neuropsychological profile of human VCI. Rather than undermine the 
extrapolation of experimental studies to human diseases, this shows the phylogenetic 
comparability of basic cognitive functions across species. 
 By chance a neglect phenomenon was observed in right hemisphere lesioned 
rats, both in the reaction time and the attention performance experiments. The syn-
drome of neglect is defined as an inability to report, respond or orient to stimuli con-
tralateral to a cerebral lesion despite intact elementary sensory or motor function. 
Such an inability to respond to the contralesional hemispace occurs frequently in 
stroke patients, particularly in right hemisphere strokes. In rats, right hemisphere 
infarction can also produce neglect phenomena. There are numerous reports show-
ing that rats subjected to stroke fail to orient toward contralateral stimuli [for review, 
see [6]]. This failure to respond following stroke can result from sensory inattention, 
inability to initiate motor responses or a combination of these two components (sen-
sorimotor desintegration). Most experimental stroke studies report hemi-inattention or 
sensorimotor integration deficits without attempting to dissociate the sensory, motor 
and motivational components. The present thesis substantiates that frontal cortex 
infarction in rat brain causes two types of neglect phenomena: (1) a sensorimotor 
disintegration of the motor preparatory process, and (2) a transient impairment in 
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spatial attention of the contralateral visual field. By contrast, parietal infarction causes 
a non-lateralized impairment of attention. Lateralization or hemispheric dominance of 
cognitive functions is therefore not exclusively a human trait. 
Vascular cognitive impairment: cholinergic analysis in rat brain 
In the second part of this thesis, the objective was to characterize alterations to the 
central cholinergic system after photothrombotic infarction in rat brain. The central 
cholinergic system is known to modulate cognitive performance. Most of the cho-
linergic nuclei are located in the basal forebrain and their axonal projections inner-
vate all layers of the cerebral cortex. These extensive projections mediate fundamen-
tal cognitive processes such as the speed of information processing in the cerebral 
cortex and attention performance by modulating stimulus selection [7]. Although 
minor differences exist in the neuroanatomy of different species of animals, the main 
cholinergic pathways that have been found in rat brain are similar to those found in 
other mammals including humans. 
 The application of the photothrombotic model described in this thesis resulted in 
transcortical infarction of all layers of the cortex, whereas additional damage to the 
corpus callosum was minimal or non-existent. Axonal damage and subsequent an-
terograde and retrograde degeneration of basal forebrain cholinergic projections are 
therefore likely to have occurred. However, infarction to the frontal cortex did not 
result in a diminished cholinergic cell number in the basal forebrain. This suggests 
that cell bodies are intact and should be capable of regenerative responses through 
secondary plastic changes. Elaborate reviews by Henderson and Hartig et al. [8,9] 
state that there is little evidence for regeneration or collateral sprouting of cholinergic 
axons in the basalo-cortical pathway. The only apparent compensatory response is 
thought to be upregulation of neurotransmitter function, as the strong muscarinic 
receptor activation after 1 week of frontal cortex infarction suggests. 
 To assess possible alterations within the central cholinergic system in vivo, 
neuroimaging of cholinergic muscarinic receptor function was performed. This 
showed widespread changes in receptor activation inside the ischemic lesion area as 
well as in areas distant from infarction, which was found particularly after right frontal 
cortex infarction. Apparently, cerebral lateralization in the rat involves functional al-
terations on neurotransmitter receptor level. 
 Chapter 7 
 112 
Vascular cognitive impairment: integrative analysis in rat brain 
The present paragraph tries to relate the observed experimental equivalents of hu-
man VCI with the ischemia-induced alterations of the cholinergic system (see Table). 
 
 
Table. Summary of results: Comparison of behavioural versus neuroimaging studies 
 RTR SSVA mAChR 
Frontal (right) <4 weeks: transient deficit in 
contralateral motor initiation 
(neglect phenomenon) 
 
>3 weeks: gradual reaction time 
increase (mental slowing) 
 
<1 week: transient deficit contra-
lateral visual attention (neglect 
phenomenon) 
week 1: high 
week 3: very low 
Frontal (left) >3 weeks: gradual reaction time 
increase (mental slowing) 
 
N/A week 1: very high 
week 3: low 
Parietal (right) N/A <1 week: non-lateralized visual 
attention deficit* 
N/A 
* Induced by scopolamine. Abbreviations: RTR = reaction time responding, and SSVA = sustained spatial 
visual attention (behavioural tasks), mAChR = muscarinic acetylcholine receptor (pharmacological MRI) 
 
 
First, a slowing of information processing speed developed gradually over the course 
of 4 weeks after infarction to the frontal cortex, which was deemed similar to the post-
stroke mental slowing observed in humans. If related to changes in the cholinergic 
system, such a gradual slowing of information processing speed may be caused by 
secondary plastic changes to cholinergic neurons or a down regulation of cholinergic 
receptors. Since the number of cell bodies was found to be intact, the cholinergic 
system should be capable of regenerative responses. Indeed, down regulation of 
muscarinic receptors was shown in this thesis by a diminished cortical activation of 
muscarinic receptors at 3 weeks after infarction to either the left or right frontal cortex. 
There is no certain explanation why reduced muscarinic receptor activation was 
found particularly after right hemisphere infarction, while the general increase in 
reaction time did not differ between right versus left hemisphere lesioned animals. 
But as mentioned in Chapter 6, it has been reported that the right cerebral cortex of 
rat brain contains higher mAChR densities compared to the left, and that the down-
regulation process of these receptors is more active in the right cerebral cortex. 
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Second, transient deficits in attention performance lasting no more than 1 week after 
right hemisphere cortical infarction were observed. After parietal infarction, this atten-
tion deficit may be related to cholinergic function since a similar non-lateralized atten-
tion deficit was found with muscarinic receptor blockade. By contrast, frontal infarc-
tion resulted predominantly in a lateralized, contralesional attention deficit that was 
explained as an attentional impairment for the left visual field, which is in accordance 
with the most prevalent form of neglect following right hemisphere damage. It re-
mains speculatory whether this neglect phenomenon involves cholinergic function. 
 Third, the testing of reaction time performance and visual attention performance 
after right frontal cortex infarction revealed two types of neglect. Phenomena associ-
ated with neglect can be interpreted along the spectrum of sensorimotor integration 
as either reflecting deficits in attentional performance (‘sensory neglect’) versus inten-
tional performance (‘motor neglect’). In accordance with the latter, this thesis reports 
on a form of motor neglect that lasted 3 to 4 weeks. It was attributed to an impairment 
of movement initiation that relates well with the functional role of the frontal cortex. 
Reduced cholinergic function may be involved, since muscarinic receptor activation 
was reduced at 3 weeks in right hemisphere infarction. However, at 1 week after 
infarction the neglect phenomenon coincided with an apparent increase in muscarinic 
activation. The present thesis indicates that neglect after right frontal infarction har-
bours a short-lived attentional component that may relate to an early reduction in 
muscarinic receptor function. However, a direct relation between left-sided neglect 
and cholinergic dysfunction was not proven. Proof would require additional experi-
mentation, for instance with direct cortical injection of muscarinic acetylcholine recep-
tor antagonists. Nonetheless, it is clearly shown that spatial visual attention is im-
paired after cortical infarction as well as after cholinergic blockade. 
 And last, it is likely that the observed behavioural deficits may not be related 
solely to alterations of the cholinergic system. Apart from acetylcholine, several other 
neurotransmitter systems are known to play a critical role in performance of cognitive 
tasks following brain damage [10]. Among these neurotransmitters are dopamine, 
noradrenaline, and glutamate. It is evident that each of these neurotransmitter sys-
tems contributes to a range of different cognitive functions, and that many of these 
functions are dependent on the action of multiple neuronal networks. Additionally, it is 
possible that some of the putative cognitive effects of these neurotransmitters are 
secondary to their effects on other cognitive systems. For example, an effect on 
memory tasks may arise from modulation of arousal or attention. The large range of 
functions in which these transmitters are implicated is reflected anatomically in their 
wide distribution across many different brain regions. 
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Future perspectives 
The photothrombotic stroke model itself has relatively limited significance in unravel-
ling the pathophysiology of cerebral ischemia or infarction, because the development 
of tissue damage is very rapid and without reperfusion or collateral blood flow. As 
discussed above, however, photothrombotic infarction of the cerebral cortex in rat 
brain does offer a means to induce certain types of behavioural effects that are ob-
served in human VCI. Additionally, it might be helpful in the development of new 
therapeutic regimens targeting VCI. In this thesis it is demonstrated that pharmacol-
ogical MRI with pilocarpine offers the possibility to study central cholinergic function 
through the activation of muscarinic receptors. Such a neuroimaging method could 
be used to detect possible cholinergic changes in cognitively impaired stroke patients 
qualitatively and quantitatively, and be used in the follow-up of patients with VCI. 
Furthermore, intervention studies with cholinergic medication in stroke patients could 
be monitored. The next two paragraphs discuss the potential for functional neuroi-
maging and neuropharmacological modulation in VCI. 
1. Functional neuroimaging in vascular cognitive impairment 
Magnetic resonance imaging (MRI) provides a non-invasive and multimodal tool to 
study neurological disorders in experimental models [11]. Routine anatomical neuro-
imaging detects cortical and subcortical infarcts, haemorrhage, white matter changes 
and gliosis. No current brain imaging techniques are capable of predicting the clinical 
presentation of VCI in stroke patients. The use of novel functional neuroimaging 
studies might help to assess pathophysiological processes, estimate the prognosis of 
functional outcome and evaluate the efficiency of treatment strategies after stroke 
[12,13]. A number of novel ways of using MRI to visualize the action of drugs on 
animal and human brain i.e. phMRI are becoming established tools in translational 
psychopharmacology. Using drugs with known pharmacology it is possible to investi-
gate how neurotransmitter systems are involved in neural systems engaged by other 
processes, such as cognitive challenge (modulation phMRI) or to examine the acute 
effects of the drug itself in the brain (challenge phMRI) [14]. 
 Pharmacological functional MRI of cholinergic receptor activation may be devel-
oped into a method whereby stroke patients can be selected to benefit from psycho-
logical and medical intervention. Our results demonstrated that ischemic brain dam-
age produces widespread functional changes in the cholinergic system. We have 
shown that cholinergic receptor function can be measured in vivo, and therefore, 
phMRI can be used in a disease model to assess the integrity of neurotransmitter 
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receptor function. Thus far, phMRI studies in rats have mainly involved the charac-
terization of drug effects on regional cerebral activation in normal rats [15]. By con-
trast, human phMRI studies investigating the cholinergic system have primarily com-
bined drug administration with a cognitive task in order to investigate drug modulation 
of the BOLD response to a cognitive challenge [16-21]. Pharmacological imaging of 
the cholinergic system could be developed for use in the diagnostic workup or 
evaluation of cognitive disorders such as VCI. Stroke patients with and without cogni-
tive impairment could then be tested for reduced cholinergic function. Ultimately, the 
effect of treatment in VCI could be monitored. 
2. Pharmacological modulation of the cholinergic system after brain ischemia 
Several studies have investigated the use of cholinesterase inhibitors on functional 
outcome after experimental stroke in rats. Zhao et al [22] did not find a beneficial 
effect of galantamine on motor recovery or spatial learning, administered prior to and 
following photothrombotic infarction of the motor cortex. By contrast, Iliev et al [23] 
showed a beneficial effect of galantamine on the recovery of learning ability when 
administered once only after transient forebrain ischaemia, suggesting a direct effect 
on the early pathologic mechanisms of central nervous system damage. Moreover, 
Borlongan et al. [24] showed that methanesulfonyl-fluoride attenuated deficits in 
learning and memory following focal cerebral ischemia, possibly by preserving a 
functional cholinergic system. 
 It may be possible to target cognitive protection in the acute human stroke set-
ting. A review by Parton et al. [10] discusses several studies that describe modulation 
of the cholinergic system in humans. Partial protection of the cholinergic system after 
ischemic injury has been reported by the use of cholinesterase inhibitors. Such 
treatment could help to preserve the cholinergic system after human brain injury, with 
the window for the initiation of treatment potentially being much larger than for current 
therapies. It may also be possible to pharmacologically treat established and chronic 
cognitive deficits. As with acute intervention, there has been considerable interest in 
the use of cholinesterase inhibitors due to the significance of the cholinergic system 
in learning, memory and arousal. Controlled clinical trials with donepezil, galantamine 
and rivastigmine in VCI have demonstrated improvements in cognition, behaviour 
and activities of daily living [25]. Limited data are available when considering the 
impact of galantamine on VCI, and there is some evidence of benefit of rivastigmine 
in VCI. Available evidence supports the benefit of donepezil in improving cognition, 
clinical global impression and activities of daily living in patients with probable or 
possible mild to moderate VCI after 6 months treatment. 
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As a result, there is generally limited enthusiasm for pharmacological intervention 
with cholinomimetic drugs in stroke patients with VCI. Other suggested therapies 
such as cognitive rehabilitation for memory deficits or spatial neglect following stroke 
have also failed to show clear evidence of effectiveness [26,27]. But a treatment 
strategy combining neuropharmacological intervention with cognitive rehabilitation 
may be of interest. In addition, pharmacological MRI of cholinergic function may be 
helpful in selecting patients that may benefit from such a combined treatment ap-
proach. 
Concluding remarks 
In the present thesis, the putative relationship between the development of VCI and 
damage to the central cholinergic system was explored in an animal model of cere-
bral cortical infarction. First, an experimental equivalent of human VCI was estab-
lished in the rat. Second, functional instead of structural changes in the central cho-
linergic system were shown to occur in rat brain by using phMRI. This neuroimaging 
method may be developed into a useful tool to detect central cholinergic impairment 
and evaluate cholinomimetic treatment in VCI. 
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ABSTRACT 
Vascular cognitive impairment (VCI) is defined as cognitive impairment of any sever-
ity associated with cerebrovascular disease. Cholinergic deficits are thought to con-
tribute to vascular cognitive impairment. After stroke, these cholinergic deficits may 
result from altered cholinergic receptor function due to ischemic damage of basal 
forebrain cholinergic nuclei or their axonal projections. The present proof-of-principle 
study aimed to detect changes in muscarinic receptor activation following subcortical 
stroke by use of pharmacological magnetic resonance imaging (phMRI) in rat brain. 
To this end, phMRI was performed 14 days after transient unilateral middle cerebral 
artery occlusion (MCAO) in rat brain. Our data demonstrate the feasibility to detect 
reduced muscarinic receptor activation inside ischemic territory as well as outside the 
lesion area, suggestive of remote functional impairment. The latter might be due to 
anterograde damage to cortically projecting cholinergic neurons resulting in altera-
tions in muscarinic receptor function. 
Muscarinic phMRI after subcortical infarction  
 121 
INTRODUCTION 
Vascular cognitive impairment (VCI) is defined as cognitive impairment of any sever-
ity associated with cerebrovascular disease [1]. Cholinergic deficits are thought to 
contribute to VCI [2]. The putative cholinergic deficits of VCI may result from altered 
cholinergic receptor function due to ischemic damage of either basal forebrain cho-
linergic nuclei or their axonal projections. Studies using autoradiographic analysis or 
immunohistochemistry have shown decreased muscarinic receptor binding activity 
and cholinergic fiber density after global and focal cerebral ischemia in rats [3-6]. 
 The aim of the present study was to investigate the feasibility of pharmacological 
magnetic resonance imaging (phMRI) to detect local and remote changes in mus-
carinic receptor activation following subcortical ischemic damage in rats. We hy-
pothesized that subcortical ischemia would result in damage to central cholinergic 
nuclei and/or its projections, and thereby, reduced muscarinic receptor activation in 
subcortical areas as well as the cerebral cortex. 
MATERIALS AND METHODS 
Transient ischemia was performed by 60-minute right-sided middle cerebral artery 
occlusion (MCAO) with an intraluminal filament in adult male Wistar rats [7, 8]. The 
extent of infarction after 60-min MCAO is variable and may include both subcortical 
and cortical areas or only subcortical areas. In this present study, four animals with 
subcortical infarction only were included. We performed contrast-enhanced CBV-
weighted phMRI in combination with injection of pilocarpine, a non-selective choliner-
gic muscarinic receptor agonist, to measure the effects on muscarinic receptor acti-
vation at 14 days after MCAO. 
 The MRI experiments were conducted as described elsewhere in this thesis 
(Chapter 5). In brief, rats were anesthetized with isoflurane and intubated endotra-
cheally. Approximately 60 minutes prior to MRI, the animals were given a subcutane-
ous injection of 1 mg/kg scopolamine methyl-bromide (Sigma-Aldrich, Zwijndrecht, 
The Netherlands) to block peripheral muscarinic effects of pilocarpine injection. T2-
weighted MRI was performed at 4.7 T (SISCO/Varian systems, Palo Alto, CA, USA) 
using a spin-echo multi-slice sequence: repetition time (TR) = 3000 ms; echo time 
(TE) = 20 ms; data matrix = 128 x 128 points; field-of-view (FOV) = 35 x 35 mm2; 16 
x 1.2-mm slices. Contrast-enhanced CBV-weighted MRI was performed using a 
gradient-echo multi-slice sequence: TR = 520 ms; TE = 23 ms; pulse angle = 41°; 
data matrix = 64 x 64 points; FOV = 35 x 35 mm2; 20 x 1.0-mm slices; temporal 
resolution = 33 s. Following 10 pre-contrast scans, we intravenously injected ultra-
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small superparamagnetic iron-oxide particles (Sinerem®, Guerbet, Aulnay-sous-Bois, 
France; 10 mg/kg). Contrast-enhanced CBV-weighted phMRI was started 15 minutes 
after injection of the contrast agent. After 10 minutes of baseline measurements (20 
scans), pilocarpine was administered and data acquisition continued for 30 minutes 
thereafter (60 scans). 
 Data analysis was conducted in three different ways. First, contrast-enhanced 
CBV-weighted phMRI data were processed and analyzed within the framework of a 
general linear model (GLM) using SPM2 software package (http://www.fil.ion.ucl.ac.-
uk/spm). Using the regressors derived previously from CBV-weighted phMRI in 
methyl-scopolamine pre-treated non-lesioned Lewis rats, we performed a first level or 
model fitting analysis in SPM2 (see also Chapter 5). Second, we used the Group ICA 
of fMRI (GIFT) software package (http://icatb.sourceforge. net) to determine up to 20 
independent components. Group-level Independent Components Analysis (ICA) has 
been shown to be a useful method in extracting components of interest from fMRI 
data [9, 10]. We used the FastICA algorithm [11] using the following algorithm pa-
rameters (default): independent components = 20; autofill data reduction = yes; epsi-
lon = 0.0001; iteration = 1000; approach = defl; g = pow3. Selection of components of 
interest was based on the following criteria: regional brain activation (sensitivity), no 
activation of extracranial areas (specificity), and a smooth signal curve shape. Third, 
relative changes in CBV were calculated from the contrast-enhanced CBV-weighted 
MR data as described previously [12]. The CBV response to pilocarpine challenge 
was analyzed in two regions-of-interest, namely the cerebral cortex and striatum, 
both ipsilateral and contralateral to the lesioned hemisphere. 
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RESULTS 
Positive cortical signal responses in the lesioned hemisphere were largely present in 
three out of four animals. In one animal, a distinct portion of the ipsilesional parietal 
cortex did not show an activation response (Figure 1). None of the lesioned animals 
showed a significant negative response in the ipsilesional striatum. These results 
were confirmed by independent component analysis, which in none of the animals 
yielded a negative subcortical component. Moreover, one positive component with a 
similar partial lack of cortical activation was found in the same one animal [data not 
shown]. 
 
 
Figure 1. Example of muscarinic activation pattern at two weeks after right-sided MCAO in a rat: Delineation 
of subcortical ischemic area on T2-weighted MRI (upper images); Statistical maps of significant pilocarpine-
induced positive CBV responses overlaid on anatomical MRI images (middle images). Note the loss of 
activation in large part of the right parietal cortex. 
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Figure 2 shows the time-course of pilocarpine-induced CBV changes in the cortex 
and striatum. In the striatum, the negative CBV response was lower in the lesioned 
hemisphere as compared to the contralateral hemisphere. In the cortex, the positive 
CBV response did not differ between hemispheres. 
 
DISCUSSION 
The results of this proof-of-principle study demonstrate the feasibility of phMRI to 
detect alterations in muscarinic receptor activation inside ischemic territory as well as 
in the parietal cortex remote from subcortical ischemia in rat brain. Ischemia-induced 
changes in brain receptor activation by means of phMRI have not been reported 
previously. Our study corroborates previous autoradiographic findings [13] that imag-
ing of muscarinic receptor function may be of value for the assessment of cholinergic 
neuron viability following brain ischemia. However, these preliminary findings need to 
be substantiated in larger series and subsequently developed into a tool suitable for 
human imaging. Ultimately, functional imaging of muscarinic receptor activation may 
be used in the diagnosis and therapeutic evaluation of human vascular cognitive 
impairment. 
Figure 2. Mean CBV change (%) to pilocarpine challenge in ipsilesional and contralesional striatum and 
cortex two weeks after unilateral MCAO in rats. Error bars represent standard deviation. 
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Cognitive impairment in stroke patients is thought to result from structural brain dam-
age to both grey and white matter, leading to functional disconnection of neuronal 
networks. This so-called ‘vascular cognitive impairment’ has been associated with 
dysfunction of the central cholinergic system. As described in chapter 1, the present 
thesis explored the putative relationship between the development of cognitive im-
pairment and damage to the central cholinergic system in an animal model of cortical 
cerebral infarction. 
 Of the numerous experimental models available to study the effects of brain 
ischemia, the photothrombotic stroke model is able to produce highly reproducible 
localized infarction of the cerebral cortex in the rat. It involves intravenous administra-
tion of a photosensitive dye followed by irradiation of a particular brain area with a 
focused light beam of a specific wavelength. The resulting lipid peroxidation of vascu-
lar endothelial membranes and platelets causes the formation of intravascular aggre-
gates. Chapter 2 describes an in vivo study extending the view of the pathophysi-
ological processes involved in the photothrombotic stroke model in the rat. It was 
found that vascular leakage plays a major role in the process of brain ischemia that 
ultimately results in focal infarction of the cerebral cortex. And probably more so than 
the direct occlusive thrombosis of the cortical microcirculation, as was described 
originally. 
 One of the major objectives of this thesis was to establish an experimental 
equivalent of human vascular cognitive impairment using the photothrombotic stroke 
model in rats. The neuropsychological profile of human vascular cognitive impairment 
is typically characterized by mental slowing: a general disturbance in the speed of 
information processing is observed in up to 70% of stroke patients. Both in humans 
and lower vertebrates like the rat, the speed of information processing can be as-
sessed by testing reaction time performance. Behavioural tasks measuring reaction 
time performance are widely employed in experimental psychology, and reaction time 
is considered a basic element of information processing that is highly comparable 
between rats and humans. In chapter 3, rats were trained in a Skinner box to master 
a reaction time paradigm. The type of reaction time testing we employed is similar to 
what is done in humans, and the nature of responding of rats in this task shows many 
similarities with that of humans. Following a random time interval, an auditory stimu-
lus was presented. A high tone required pressing the left lever to obtain a food re-
ward, whereas a low tone required pressing the right lever. The main behavioural 
outcomes in this behavioural task are: (1) reaction time i.e. retraction of the head 
from a hinged panel, and (2) motor time, being the latency between panel release 
and lever press. After unilateral frontal cortex infarction, reaction time performance 
was shown to be differentially affected between left versus right-hemisphere lesioned 
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animals. Apart from a general reaction time increase of about 10% in both lesion 
groups, a lateralized deficit was present only after right frontal infarction as a reaction 
time increase of 10-15% in trials directed towards the contralesional side. These two 
types of reaction time deficits can be explained differently. The former resembles a 
gradual and general decrease in the speed of information processing that matches 
well with the mental slowing observed in stroke patients. The latter shows a specific 
impairment to initiate a contralateral motor response. Such an inability to respond to 
the contralesional hemispace occurs frequently in stroke patients, specifically in right 
hemisphere strokes, and is known as a neglect phenomenon. Therefore, reaction 
time performance after frontal cortical infarction in rats may be a useful tool to study 
particular human cognitive impairments observed in stroke patients. 
 Apart from deficits in information processing speed, the neuropsychological pro-
file of vascular cognitive impairment also includes impairments in attention perform-
ance that is typically seen in patients with right hemisphere strokes. To this end, the 
effects of right-hemisphere photothrombotic infarction to either the frontal cortex or 
the parietal cortex in a behavioural paradigm measuring spatial visual attention were 
studied in chapter 4. In this behavioural task, a light stimulus was presented either 
on the left side or on the right side of a food reward tray. One second after the light 
stimulus was extinguished, two levers were inserted simultaneously into the Skinner 
box. When the rat hit the lever on the side of the prior light stimulus (correct re-
sponse), the rat was rewarded with a food pellet. When the rat hit the lever on the 
opposite side of the previous light stimulus (incorrect response), the rat was not re-
warded. When the rat did not hit either lever within 3 seconds (omission), the rat was 
not rewarded. Our results showed a transient response bias immediately after frontal 
infarction, with a decrease in the percentage of correct responses contralateral to the 
lesion and an increase in contralesional omissions. Parietal infarction also resulted in 
a decrease in correct responses and an increase in omissions, albeit without a differ-
ence in side responding. Right frontal infarction thus induces a transient impairment 
in contralesional spatial visual attention that we explain as left-sided neglect, whereas 
right parietal infarction shows non-lateralized deficits in spatial visual attention, sug-
gestive of global attentional impairment. This confirms the role of the right hemi-
sphere’s frontal and parietal cortices in attention performance. 
 Another major objective of this thesis was to characterize structural and func-
tional changes to the central cholinergic system after photothrombotic cortical infarc-
tion in rat brain. Among other modulatory functions, the central cholinergic system is 
known to modulate attention performance. Therefore, the effect of cholinergic recep-
tor blockade with scopolamine was studied in our behavioural paradigm measuring 
spatial visual attention. Systemic administration of scopolamine resulted in a de-
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crease in correct responses and an increase in omissions, without a difference in 
side responding. Cholinergic blockade thus showed non-lateralized deficits in spatial 
visual attention, suggestive of global attentional impairment. As such, the results 
described in chapter 4 underscore the well-known involvement of the cholinergic 
system in cognitive performance. 
 Next, a method was sought that would enable whole-brain assessment of the 
cholinergic system in a living animal. Functional imaging of this neurotransmitter 
system may provide novel opportunities in the diagnosis and evaluation of cognitive 
disorders. A number of novel ways of using functional magnetic resonance imaging 
(fMRI) to visualise the action of drugs on animal and human brain are becoming 
established tools in translational psychopharmacology. Chapter 5 describes the 
feasibility of pharmacological magnetic resonance imaging (phMRI) as a means to 
detect cholinergic muscarinic receptor activation in rat brain. Blood oxygenation level-
dependent (BOLD) MRI and contrast-enhanced cerebral blood volume (CBV)-
weighted MRI were conducted during pharmacological stimulation with pilocarpine, a 
non-selective muscarinic acetylcholine receptor agonist. BOLD and CBV responses 
were assessed in drug-naïve rats, and in rats pretreated with methyl-scopolamine in 
order to block peripheral muscarinic effects. Both in drug-naïve and methyl-
scopolamine pretreated animals, pilocarpine induced significant BOLD signal in-
creases primarily in the cerebral cortex. With contrast-enhanced CBV-weighted MRI, 
positive CBV responses were detected in the cerebral cortex, thalamus, and hippo-
campus whereas a negative CBV response was observed in the corpus striatum. It 
was concluded that pilocarpine induced significant activation responses in brain re-
gions that are known to have a high density of muscarinic receptors. These experi-
ments demonstrate that phMRI of muscarinic receptor stimulation in rats allows func-
tional assessment of the cholinergic system in vivo. Subsequently, this neuroimaging 
method was applied to measure cholinergic muscarinic receptor activation after brain 
infarction, as is described in the appendix. It was hypothesized that subcortical 
ischemia would result in the degeneration of cholinergic projections toward the cere-
bral cortex, and thereby reduced cortical muscarinic receptor activation. Transient 
middle cerebral artery occlusion was performed to induce subcortical ischemia in a 
small number of rats, followed after two weeks by phMRI of muscarinic receptor 
activation. The results of this pilot study suggest that direct subcortical ischemic 
damage leads to diminished striatal muscarinic receptor activation as well as dimin-
ished muscarinic receptor stimulation in the cerebral cortex. However, further ex-
periments are required to establish these preliminary findings. 
 Chapter 6 reports on remote effects of photothrombotic infarction to the frontal 
cortex on muscarinic receptor activation as well as cholinergic cell number and vol-
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ume in several basal forebrain nuclei. First, phMRI assessing cerebral muscarinic 
receptor activation was performed at 1 and 3 weeks after left or right frontal cortex 
infarction. We found near-significant reductions in muscarinic receptor activation 
inside the ischemic area after right-sided cortical infarction. Moreover, significant 
activation changes at 3 weeks after right-hemisphere infarction were found in the 
motor cortex adjacent to the lesion, and in the sensory cortex as well as striatum 
distant from the lesion. Second, stereological assessment of choline acetyltrans-
ferase (ChAT)-immunopositive cells was conducted in several basal forebrain nuclei. 
No significant alterations were found in cholinergic cell number and volume following 
focal infarction to the right of left frontal cortex. Since cholinergic projections do not 
seem to degenerate after focal cortical infarction, functional imaging of muscarinic 
receptor activation may provide a sensitive tool for the evaluation of therapy in vascu-
lar cognitive impairment. 
 Finally, in chapter 7 the results of the conducted studies are discussed and 
recommendations for future research are made. 
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Cognitieve stoornissen bij patiënten met een beroerte worden verondersteld het 
resultaat te zijn van structurele hersenschade van zowel grijze als witte stof, leidend 
tot functionele disconnectie van neuronale netwerken. Deze zogenaamde ‘vasculaire 
cognitieve beperking’ is geassocieerd met disfunctie van het centrale cholinerge 
systeem. Zoals beschreven in hoofdstuk 1, richt dit proefschrift zich op de veronder-
stelde relatie tussen het ontstaan van cognitieve stoornissen en beschadiging van 
het centrale cholinerge systeem in een diermodel voor het herseninfarct. 
 Van de vele diermodellen die beschikbaar zijn voor het bestuderen van de effec-
ten van hersenischemie, is het met behulp van het fototrombotisch model mogelijk 
zeer reproduceerbare en gelokaliseerde infarcten in de hersenschors bij de rat te 
verkrijgen. Hierbij wordt een lichtgevoelige kleurstof intraveneus ingespoten waarna 
door de schedel heen een hersengebied wordt beschenen met een lichtstraal van 
specifieke golflengte (laser). Dit leidt via lipidperoxidatie van vaatendotheel en bloed-
plaatjes tot vorming van aggregaten en dientengevolge microvasculaire trombose. 
Hoofdstuk 2 beschrijft een studie die de kijk op de pathofysiologische processen 
betrokken bij fototrombotisch model voor herseninfarcering verbreedt. Vaatlekkage 
blijkt een belangrijke rol te spelen in het ontstaan van een herseninfarct. En waar-
schijnlijk zelfs meer dan de microvasculaire trombose zoals die oorspronkelijk werd 
beschreven. 
 Een van de voornaamste doelen van dit proefschrift was het ontwikkelen van een 
experimenteel equivalent van vasculaire cognitieve stoornissen in mensen, gebruik-
makend van het fototrombotisch beroertemodel in ratten. Het neuropsychologische 
profiel van vasculaire cognitieve beperking wordt vooral gekenmerkt door mentale 
traagheid: verstoring van de snelheid van informatieverwerking wordt gezien bij on-
geveer 70% van de patiënten met een beroerte. Zowel bij mensen als lagere gewer-
velde dieren zoals de rat, kan de snelheid van informatieverwerking worden bepaald 
door testen van het reactievermogen. Gedragstaken die de reactietijd meten, worden 
breed toegepast in de experimentele psychologie. Reactiesnelheid wordt gezien als 
de basis van informatieverwerking, en is gebleken vergelijkbaar te zijn tussen ratten 
en mensen. 
 In hoofdstuk 3 werden ratten in een Skinner box getraind om een reactietijdtaak 
te beheersen. Het type reactietest dat werd gebruikt is gelijk aan dat bij mensen, en 
de aard van de respons bij ratten vertoont in deze taak veel gelijkenissen met die bij 
mensen. De taak begint met een geluidsstimulus die wordt gepresenteerd terwijl een 
rat met zijn hoofd tegen een paneel rust. Bij een hoge toon levert het indrukken van 
het pedaal links met het hoofd een voedselbeloning op, terwijl bij een lage toon het 
indrukken van het pedaal rechts van het hoofd nodig is voor het krijgen van een 
voedselbeloning. De belangrijkste uitkomstmaten in deze gedragstaak zijn: (1) reac-
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tietijd, te weten de tijd benodigd voor terugtrekken van het hoofd, en (2) motortijd, 
zijnde de latentie tussen terugtrekken van het hoofd en indrukken van het pedaal. 
Het reactievermogen bleek op verschillende manieren te zijn aangedaan bij ratten 
met een herseninfarct. Enerzijds was er een algemene toename in reactietijd bij 
ratten met een herseninfarct in de frontale hersenschors van de linker of rechter 
hersenhelft. Anderzijds was er een gelateraliseerd defect specifiek voor het reactie-
vermogen naar links bij ratten met een herseninfarct in de rechter hemisfeer. Deze 
twee soorten stoornissen in reactiesnelheid kunnen verschillend verklaard worden. 
De graduele en algemene afname in de snelheid van informatieverwerking past bij 
de mentale vertraging zoals die gezien wordt bij beroertepatiënten. De specifieke 
beperking tot het initiëren van een contralaterale respons komt ook bij patiënten met 
een beroerte in de rechter hersenhelft vaak voor, en staat bekend als een neglect 
fenomeen. Hierbij zijn de zintuiglijke functies intact, maar is er desondanks een on-
vermogen tot het reageren op stimuli aan de zijde contralateraal van het letsel in de 
hersenen. Testen van het reactievermogen bij ratten met een herseninfarct van de 
frontale hersenschors kan hierom een bruikbaar instrument zijn voor het bestuderen 
van bepaalde cognitieve stoornissen zoals die voorkomen bij beroertepatiënten. 
 Naast tekorten in de snelheid van informatieverwerking, wordt het neuropsycho-
logische profiel van vasculaire cognitieve beperking ook gekenmerkt door stoornis-
sen in aandachtsfuncties, vooral bij patiënten met een beroerte in de rechter hersen-
helft. Hierom werden in hoofdstuk 4 gedragseffecten gemeten na fototrombotische 
herseninfarcering in ofwel de frontale ofwel de parietale schors van de rechter her-
senhelft. In de gebruikte aandachtstaak werd een lichtstimulus gepresenteerd aan 
ofwel de linkerkant ofwel de rechterkant van de rat. Vervolgens werden aan weerszij-
den van de rat simultaan twee pedalen in de Skinner box gebracht. Wanneer de rat 
het pedaal aan de kant van de voorafgaande lichtstimulus indrukte (correcte res-
pons), werd deze beloond met voedsel. Wanneer de rat het pedaal indrukte aan de 
tegenovergestelde kant van de voorafgaande lichtstimulus (incorrecte respons), werd 
deze niet beloond. Wanneer de rat binnen 3 seconden geen van beide pedalen in-
drukte (omissie), werd deze ook niet beloond. In de eerste dagen na een frontaal 
hersenschorsinfarct werd een transiënte responsfout gezien, met een afname in het 
percentage van correcte responsen en een toename in het aantal omissies contrala-
teraal van het letsel. Ook infarcering van de parietale hersenschors resulteerde in 
een afname van het percentage correcte responsen en een toename in het aantal 
omissies, doch zonder verschil tussen contralaterale en ipsilaterale responsen. Bij 
ratten induceert een infarct van de rechter frontale hersenschors dus een tijdelijke 
stoornis in ruimtelijke visuele aandacht contralateraal aan het letsel, hetgeen te ver-
klaren is als een linkszijdig neglect fenomeen. Een infarct van de rechter parietale 
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hersenschors leidt echter tot een globaal tekort in ruimtelijke visuele aandacht. Deze 
studie bevestigt de rol van de frontale en parietale schors van rechter hersenhelft in 
aandachtsfuncties. 
 Een ander belangrijk doel van dit proefschrift was het karakteriseren van structu-
rele en functionele veranderingen in het centrale cholinerge systeem na fototromboti-
sche infarcering in rattenhersenen. Het is bekend dat het centrale cholinerge sys-
teem onder andere een modulerende rol speelt bij aandachtsfuncties. Daarom werd 
het effect bestudeerd van blokkade van cholinerge receptoren door scopolamine in 
de bovenbeschreven gedragstaak voor ruimtelijke visuele aandacht. Systemische 
toediening van scopolamine resulteerde in een afname van correcte responsen en 
een toename van omissies, zonder verschil tussen contralaterale en ipsilaterale 
responsen. Net als na infarcering van de rechter parietale hersenschors, leidt bloka-
de van cholinerge receptoren dus tot een globaal tekort in ruimtelijke visuele aan-
dacht. Zodoende onderstrepen de resultaten beschreven in hoofdstuk 4 de betrok-
kenheid van het cholinerge systeem bij cognitief functioneren. 
 Vervolgens is een methode gezocht waarmee het cholinerge systeem van de 
hersenen in zijn geheel zichtbaar te maken zou kunnen zijn bij een levend wezen. 
Functionele beeldvorming van dit neurotransmittersysteem biedt wellicht nieuwe 
mogelijkheden voor de diagnose en evaluatie van cognitieve stoornissen bij mensen. 
Hoofdstuk 5 beschrijft de haalbaarheid van farmacologische magnetische resonan-
tie beeldvorming (phMRI) als een instrument voor het detecteren van cholinerge 
muscarine receptoractivatie in rattenhersenen. Blood oxygenation level-dependent 
(BOLD-MRI) en contrastversterkte cerebral blood volume (CBV)-gewogen MRI wer-
den uitgevoerd gedurende toediening van pilocarpine, een niet-selectieve muscarine 
acetylcholine receptor agonist. BOLD- en CBV-responsen werden bepaald in ratten 
waarbij perifeer muscarinerge effecten geblokkeerd waren met methylscopolamine, 
dat de bloed-hersenbarriere niet passeert. Pilocarpine veroorzaakte een significante 
toename in BOLD signaal, voornamelijk in de cerebrale cortex. Met contrastversterk-
te CBV-gewogen MRI werden positieve CBV responsen gevonden in de cerebrale 
cortex, thalamus en hippocampus; een negatieve CBV-respons werd geobserveerd 
in het striatum. Toediening van pilocarpine leidt derhalve tot veranderingen in her-
sengebieden die een hoge dichtheid van muscarine receptoren kennen. Deze expe-
rimenten tonen aan dat phMRI met muscarine receptor stimulatie in ratten een func-
tionele beoordeling van het cholinerge systeem in vivo mogelijk maakt. Vervolgens 
werd deze beeldvormende techniek gebruikt voor het detecteren van cholinerge 
muscarine receptor activatie na herseninfarcering (appendix). De hypothese was dat 
subcorticale ischemie zou resulteren in degeneratie van cholinerge projecties naar de 
cerebrale cortex, en zodoende zou leiden tot een afname in corticale muscarine 
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receptor activatie. Subcorticale ischemie werd geïnduceerd door transiënte occlusie 
van de arteria cerebri media, en na twee weken gevolgd door phMRI van muscarine 
receptor activatie. De resultaten van deze pilot studie suggereren dat subcorticale 
ischemische schade leidt tot verlaagde muscarine receptor activatie in zowel het 
striatum als de cerebrale cortex. Aanvullende experimenten zijn echter nodig voor het 
bevestigen van deze voorlopige resultaten. 
 Hoofdstuk 6 rapporteert de effecten van fototrombotische infarcering van de 
frontale hersenschors op zowel muscarine receptor activatie als het aantal en volume 
van cholinerge cellen in verscheidene kernen in de basale voorhersenen. Ten eerste 
werd phMRI toegepast voor het beoordelen van cerebrale muscarine receptor activa-
tie 1 en 3 weken na infarcering van de linker danwel rechter frontale hersenschors. 
Er werd een afname van muscarine receptor activatie gevonden binnen het ische-
misch gebied na rechtszijdige corticale infarcering. Daarenboven werden 3 weken na 
infarcering van de rechter frontale hersenschors significante activatieveranderingen 
gevonden op afstand van het ischemisch gebied, te weten in de motore schors gren-
zend aan het ischemisch letsel en in de sensore cortex op grotere afstand. Ten 
tweede werd miscroscopische beoordeling van cholinerge acetyltransferase (ChAT)-
immunopositieve cellen uitgevoerd in verscheidene kernen in de basale voorherse-
nen. Er werden geen significante veranderingen gevonden in het aantal en volume 
cholinerge cellen na infarcering van de rechter danwel linker frontale hersenschors. 
Omdat cholinerge projecties niet structureel lijken te degenereren na infarcering van 
de hersenschors, kan functionele beeldvorming van muscarine receptor activatie een 
gevoelig instrument zijn voor de evaluatie van therapie bij vasculaire cognitieve be-
perking. 
 Ten slotte worden in hoofdstuk 7 de resultaten van de uitgevoerde studies be-
discussieerd en aanbevelingen voor toekomstig onderzoek gedaan. 
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Dit is wat ik altijd al heb willen doen: eigen onderzoek. Ooit kwam de promovendus 
na jarenlang vorsen met een “Eureka!” van zolder om zijn ontdekkingen aan de we-
reld te presenteren. Tegenwoordig dienen de resultaten van veelal vooropgezet 
onderzoek binnen een viertal jaren op de plank te liggen. Ik ben blij dat in de huidige 
tijd, het in dit proefschrift beschreven onderzoek zijn eigen koers heeft kunnen varen. 
Graag zou ik langs deze weg de mensen die hieraan hebben bijgedragen willen 
bedanken voor het geduld, vertrouwen en het wijzen van de weg. 
 
Op weg. Harry Steinbusch, bedankt voor alles wat je voor mij en mijn onderzoek 
hebt gedaan. Onder jouw leiding biedt het laboratorium Basale Neurowetenschappen 
een stimulerende en internationale smeltkroes waar ideeën vrijelijk kunnen worden 
ontwikkeld. Jaap Troost, jij schiep de mogelijkheid om vanuit ziekenhuis naar labora-
torium en weer terug te komen. Door de loop der dingen was promotorschap niet 
meer mogelijk, maar ik ben blij dat je tot het eind toe een rol bent blijven spelen. 
Martien Limburg, jij faciliteerde wanneer nodig het afronden van dit onderzoek tijdens 
mijn opleiding tot neuroloog. Robert van Oostenbrugge, we gingen in het begin letter-
lijk de boot in en figuurlijk bijna. Mede door jouw manier van begeleiden is dit onder-
zoek komen bovendrijven. Die manier waardeer ik enorm en ligt mij erg goed: open, 
kritisch en geduldig. Rick Dijkhuizen, wat als spin-off begon is uitgegroeid tot de 
ongeveer de helft van dit proefschrift. Haast belangeloos stond jij altijd met raad en 
daad klaar. Je oprechtheid, enthousiasme en oprecht enthousiaste reactie toen ik je 
vroeg of je compromotor wilde zijn, sieren je. 
 
Het ruime sop. Het laboratorium Basale Neurowetenschappen is waar de trossen 
werden los gegooid. Ik dank Wiel Honig en Richard Frijnts voor het leren omgaan 
met proefdieren en de nodige assistentie bij opzet en uitvoer van de fototrombose. Er 
volgde een kort intermezzo op het microcirculatie laboratorium van de afdeling Fysio-
logie, waarbij de begeleiding van Mirjam oude Egbrink en Viviane Heijnen onmisbaar 
waren. Arjan Blokland, jij hebt mijn aanvankelijke scepsis met betrekking tot ge-
dragsonderzoek bij ratten gelogenstraft. Dank voor de prettige samenwerking. Kris 
Rutten en Marjolein Liedenbaum, jullie geweldige inzet en resultaten vormden de 
basis voor wat uiteindelijk dit proefschrift is geworden. Voor het bijbrengen van de 
mores van het lab, leren werken met microscoop en supervisie bij kleuringen is de 
twee-eenheid Hellen Steinbusch en Marjan Markerink van onnoembaar belang ge-
weest. Anouk Roemen, jij optimaliseerde het kleuringsprotocol voor de volumemetin-
gen van het infarct. Lillian Garrett, thanks so much in joining me for countless hours 
of stoic cell counting. Er is nu echt een eind gekomen aan een periode van mannelij-
ke AiO’s, onderzoeksmannen van het eerste uur: Ronald Deumens, Guido Koop-
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mans, Daniel van den Hove, Bart Rutten en Yasin Temel. Gezelligheid kent geen tijd, 
wel mooie herinneringen. Sitting on a sack of beans, sitting down in New Orleans, 
you wouldn’t believe what I’ve seen (Apache Rose Peacock, Red Hot Chili Peppers). 
 
De Cycloop. Halverwege werd aangemeerd bij het laboratorium In Vivo NMR te 
Utrecht. Gerard van Vliet en Annette van der Toorn dank ik voor hun stille kracht. 
Zonder jullie kan er geen scan worden gemaakt. Ona Wu, you introduced me into the 
world of MR data processing and analysis, which regularly flabbergasted me. Jet van 
der Zijden, sommige van jouw ogenschijnlijk mislukte experimenten kwamen mij zeer 
goed van pas. Raoul Oude Engberink, jij bood me geregeld port en een slaapplaats 
en ik bewaar zeer goede herinneringen aan onze samenwerking. Wim Otte en Kajo 
van der Marel, jullie bereidwilligheid om op de meest onverwachte momenten de data 
aan weer een hernieuwde analyse te onderwerpen is indrukwekkend. Nog een laats-
te list en dan kan komen we wel weg. Er is licht aan het eind van het boorgat. 
 
Een aparte vermelding verdient studievriend Remco Knol. Ik kan je altijd bellen voor 
een illustratie of figuur. Er zullen ongetwijfeld nog verzoeken volgen. Dank in ieder 
geval voor het dorsaal aanzicht van de rattenhersenen (cover, hoofdstukken 3 en 4). 
Ook dank ik Stefan Dieleman voor hulp bij de offline bloeddrukmetingen (hoofdstuk 
5). And Guerbet Group for kindly providing Sinerem® (hoofdstukken 5, 6, Appendix). 
 
Mijn paranimfen. Govert Hoogland, wij deelden jarenlang een kamer en sindsdien 
steeds meer van het leven. Vaderschap, sport, theater. Daarnaast is er veel wat een 
dokter van een doctor kan leren. Jeroen Trip, ook onze levens kruisen elkaar de 
laatste jaren steeds meer, zowel in het werk als daarbuiten. Er valt nog genoeg uit te 
kristalliseren. Ik ben trots dat jullie naast mij willen staan tijdens de verdediging van 
dit proefschrift. 
 
Mijn ouders.  Renne van Ruth, Henk Hoff en Aaltje de Vries. Jullie hebben me on-
gedwongen gevormd en altijd gesteund. Dankzij jullie voel ik me overal thuis. 
 
Mijn Sirenen. Danitsja, lief, wat moet ik zonder jou beginnen? Jij hebt niet alleen dit 
proefschrift vorm gegeven, maar mijn hele leven. Samen met Lenore, onze lieve 
kleine meid. Ik luister zo graag naar jullie lied. Nu zal daar meer tijd voor zijn. Haal de 
was uit mijn oren en snij me los. 
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